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GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation contains two separate manuscripts which have not been submitted 
for publication. Each individual manuscript is complete in itself and includes an Abstract, 
Introduction, Materials and Methods, Results, Discussion, and Reference section. The 
Ph.D. candidate, Ismail Meral, is the senior author for each manuscript. The first 
man\iscript describes the functional changes in isolated guinea-pig papillary muscle 
induced by monensin and digoxin and the second manuscript describes digoxin- and 
monensin- induced changes of intracellular Ca concentration in isolated guinea-pig 
ventricular myocytes. In addition, a current review of the literature relevant to this 
dissertation, a General Discussion section and an Appendix are included. 
Research Objectives 
The goals of this research were: 1) to compare the positive inotropic action of 
digoxin and monensin using fatigued and non-fatigued guinea-pig papillary muscles. 
Papillary muscle contractility was monitored for four hours following drug administration 
to evaluate the effects of these two drags over time. Since the inotropic action of digoxin is 
much greater in severely depressed muscle than in normal muscle (Hoffinan and Bigger, 
1990), the intent of this research was to also compare non-fatigued and fatigued guinea-pig 
papillary muscles regarding their response to digoxin and monensin; 2) to investigate the 
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possible mechanisms of action of monensin and digoxin by using isolated gxiinea-pig 
ventricular myocytes. Because Ca^"^ is a major signal for triggering contraction of cardiac 
muscle, another objective of this research was to determine whether monensin- or digoxin-
induced enhancement of cardiac muscle contraction is mediated through an increase in Ca"^ 
influx or a release from intracellular stores; 3) to establish the feasibility for further 
investigation of monensin for the possibility of using it for the treatment of congestive heart 
failure. 
J 
LITERATURE REVIEW 
This section provides concise background information for intracellular Ca^"^ 
homeostasis and the best known actions of monensin and digoxin in cardiac myocytes. 
Intracellular Ca^* Homeostasis in Cardiac Myocytes 
Ca^"^ homeostasis in cardiac myocytes is fimctionally important for at least three 
reasons (Bany and Bridge, 1993): 1) control of resting intracellular calcium concentration 
([Ca^^]i); 2) excitation-contraction coupling; 3) relaxation of the ventricular myocytes. 
1). Control of Resting [Ca^*]j 
Various ion channels and transport proteins involved in Ca^"^ homeostasis in the 
cardiac myocyte are shown schematically in Fig. 1. In the resting ventricular myocyte, the 
[Ca ]i is influenced by a Ca entry (influx) that is compensated for by an ATP-dependent 
sarcolemmal pump and the sarcolemmal Na'^ -Ca '^*" exchanger (Barry and Bridge, 
1993) that cause a Ca^"^ exit (efflux). 
The Na^-Ca^"*" exchanger has recently been cloned by Nicole et al., 1990. The 
complementary DNA encodes a protein of 970 amino acids with a molecular mass of 108 
KDa. The protein can be divided into three regions; a hydrophobic NH2 terminal portion 
containing six potential membrane-spanning segments; a long hydrophilic region that is 
modeled as a large cytoplasmic loop; and a hydrophobic COOH terminal portion 
Fig. 1. Schematic illustration of the sequence of the processes ongoing in the 
resting myocyte or at the end of diastole (Adapted from Baiiy and Bridge, 
Circulation, Vol. 87,1993, page 1808). SR, sarcoplasmic reticulum; SL, 
sarcolemma. 
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comprising six potential membrane-spanning segments (Barry and Bridge, 1993). At this 
time, little is known about relations between structure and function of this molecule. 
Modem experiments investigating the binding of antibodies to the Na'*'-Ca '^^  
exchanger with immimofluorescence and immunoelectron microscopy indicate that 
although the exchanger is detectable over the entire myocyte surface, antibody binding sites 
appear to be concentrated in the T-tubule region of the myocyte (Frank et al., 1992). The 
ftinctional significance of this arrangement is not yet clear. 
The Na^-Ca^"^ exchanger is a counterion transporter. Three Na^ ions are exchanged 
2*^ for each Ca ion which results in a positive charge movement that opposes the direction of 
Ca^"^ transport (Reeves and Hale, 1984). 
The Na -Ca exchanger is also voltage sensitive and if the membrane potential is 
more negative than the reversal potential, as is normally the case in the resting myocyte, the 
exchanger fimctions in a Na^ (in) /Ca^^ (out) mode and thus produces Ca^"^ extrusion 
(Kimura et al., 1986). 
The importance of the Na^ -Ca^^ exchanger in regiilating the resting level of Ca^"^ 
within the cardiac myocytes was demonstrated most directly by the experiments of Sheu 
and Fozzard (1982), who measured intracellular sodiimi concentration ([Na"^];) and 
activities in cardiac purkinje cells with ion sensitive microelectrodes. These experiments 
revealed a direct relation between [Na^; and [Ca^^jj. Thus, increases in [Na"^]i cause 
dissipation of the electrochemical energy in the Na^ gradient available to extrude Ca^"^, 
resulting in an increase in [Ca^^-,. The level of [Na^]; in myocytes is controlled largely by 
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Na^, K'^ -ATPase, and thus the Na^ pump is also an important indirect regulator of the Na"^-
Ca^* exchange (Barry and Bridge, 1993). 
The activity of the Na"" -Ca^"^ exchanger can also be modulated by a variety of other 
mechanisms. The effects of pH on the Na^-Ca^"^ exchange in cardiac sarcolemmal vesicles 
has been investigated by Philipson et al., 1982. It has been demonstrated that an acidosis 
inhibits the exchanger, whereas an alkalosis stimulates the exchanger. Haworth et al., 1987 
demonstrated an inhibition of Ca^^ influx due to an inhibition in the Na^-Ca^"^ exchange in 
isolated adult rat heart cells by ATP depletion. It is likely that ATP increases the affinity of 
the exchanger for Ca^"*" (dePoIo and Beauge, 1986), but it has not yet been demonstrated 
that the protein kinase-mediated phosphorylation of the exchanger has any regulatory 
influences (Barry and Bridge, 1993). 
Recently, a Na"^-Ca^^ exchanger inhibitory peptide which is identical to the 
calmodulin-binding sequence of the exchanger and effectively inhibits exchange has been 
synthesized (Li et al., 1991). It has not been established, however, that this calmodulin-
binding peptide sequence within the exchanger exerts any autoinhibitory effect under 
normal physiological conditions (Barry and Bridge, 1993). 
Another Ca^"^ transport system that contributes to maintenance of the low [Ca^^]i in 
ventricular myocytes during diastole is the sarcolemmal Ca '^*'-ATPase. The structure and 
function of plasma membrane Ca '^^ -ATPase have recently been reviewed by Carafoli, 1992. 
2+ The plasmalemmal Ca -ATPases are found in many cells and use the free energy released 
by the hydrolysis of one ATP to transport one out of the cell against its concentration 
8 
gradient General properties of the plasmaiemmal Ca -ATPases include a molecular mass 
of 134,000 Da, stimulation by Ca^"*" calmodulin and possibly a kinase-induced 
phosphorylation. 
The Na^exchanger accounts for as much as 75% of Ca^"^ efflux in the resting 
cell (Cannel, 1991). Thus, although the saicolemmal Ca -ATPase probably contributes to 
maintenance of [Ca^"^]! in resting myocytes, its importance in this regard relative to the Na^ 
-Ca^^ exchanger seems to be minor. 
2. Excitation-Contraction Coupling 
In cardiac myocytes, the transition from the resting relaxed state with low [Ca^"^]; to 
a contraction occurs because a small quantity of Ca crosses the sarcolemma and induces a 
2+ 
much larger release of Ca from the sarcoplasmic reticulum (SR). This process is initiated 
by depolarization of the cell membrane, which causes opening of voltage-gated Na^ and 
^ J 
Ca channels. The initial upstroke of the action potential in ventricular cardiac myocytes 
is caused by a Na"^ influx via the Na^ channels, whereas the subsequent inward current 
maintaining the plateau of the action potential is caused primarily by Ca influx via the L-
type Ca^"^ channels. Cumulative Na"^ influx via the Na^ chaimels also contributes to 
m^tenance of the [Na'^ ]; in myocytes and thus can influence [Ca^"^]; via the Na^-Ca^"^ 
exchange (Barry and Bridge, 1993). It has been suggested that it is the Ca^"^ release in 
response to increased [Ca ]; through opening of the L-type Ca channels that is 
considered to be of greatest importance in excitation-contraction coupling (duBell and 
9 
Hauser, 1989 and Niggli and Lederer, 1990). The initial events that couple excitation to 
contraction are displayed in Fig. 2A. 
The L-type Ce?* channel is an oligomeric complex of five subunits (Catterall, 1991 
and Singer et al., 1991). These subunits are designated as alphal, alpha2, beta, gamma, and 
delta- The alphal subunit seems to provide the primary structural and functional basis for 
the assembled channel. For example, it contains the receptor for at least three classes of 
channel antagonists, including the dihydropyridines; it contains phosphorylation sites for 
cAMP-dependent protein kinase; and it is known to contain the pore of the charmel (Barry 
and Bridge, 1993). 
An important pharmacological characteristic of the L-type Ca^"^-channels is that 
they contain a high affinity receptor for 1,4-dihydropyridine ligands (Barry and Bridge, 
1993). These ligands can fiinction either as antagonists or agonists. Antagonists such as 
nifedipine, when bound to the channels, effectively block their activity (Barry and Bridge, 
1993). Bay K 8644 is a dihydropyridine receptor agonist that increases current carried 
by the L-type Ca^"*" charmels (Sanguinetti et al., 1986 ). 
It appears that Ca^"^ influx via the Na"*" -Ca^"^ exchanger (reverse mode) can also 
occur during initial depolarization. This process may be further stimulated by [Na"^]; 
caused by the Na"^ influx via the cardiac Na"^ channels (Niggli and Lederer, 1990). 
However, it has been questioned whether or not this occurs during normal excitation-
contraction coupling (Sham et al., 1992). 
Fig. 2. Schematic illustration of the excitation-contraction coupling in an adult 
mammalian ventricular myocyte (Adapted from Barry and Bridge, 
Circulation, Vol. 87,1993, page 1809). SR, sarcoplasmic reticulum; SL, 
sarcolemma. A. Initial phase. 
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Ca^"^ that enters the cell early after depolarization via the L-type channels, and 
possibly on the Na^ -Ca^"^ exchanger, can bmd to the Ca^"^ release channels of the SR (fig. 
2A) and activate these channels (Fabiato, 1983), causing release of Ca^^ from the SR (Ca^"^-
induced Ca^^ release). 
The release channels in the SR have been cloned by Otsu et al., 1990 and have 
been shown to be a 4,969-amino acid protein with a molecular mass of 564,711 Da. The 
probability of opening of these channels is markedly increased by exposure to micromolar 
concentrations of Ca^"^ (Anderson et al., 1989 and Rousseau et al., 1987). These channels 
can also be opened by methylxanthines, such as caffeine (Meissner and Henderson, 1987). 
In low concentrations (<10 joM), ryanodine opens Ca^^ release channels of the SR 
(Rousseau et al., 1987) and at higher concentrations, ryanodine completely blocks the SR 
Ca^"^ release chaimels (Meissner, 1986). 
It has been suggested (Moravec and Bond, 1991) that not all the Ca^"^ within the SR 
is released with each beat and that SR-Ca^"^ release can be graded by the amount of trigger 
Ca^"^ entering the cell. The evidence indicating a central role for channels in this 
process has recently been summarized by Fabiato, 1989. The spontaneously released 
from a Ca '^^ -overloaded SR may induce adjacent SR Ca^^ release channels to release 
resulting in an increased [Ca^"^]i and contraction (William et al., 1992). However, the Ca^"^ 
released from the SR does not activate adjacent SR Ca^^ release channels under conditions 
of normal excitation-contraction coupling. This issue is still not satisfactorily resolved 
(Niggli and Lederer, 1990). 
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The Ca^"^ that is released from the SR initiates contraction (Fig. 2B) by binding to 
the contractile proteins (Moss, 1992). In the resting state, the interaction of actin and 
myosin is inhibited by the troponin-tropomyosin complex, which is bound to actin. When 
2+ Ca binds to troponin C, a conformational change is induced that results in relief of this 
inhibition, with cross-bridge interaction and contractile element shortening. The affinity of 
troponin C for Cs?* could be lowered by a decreased pHj (Blanchard and Solaro, 1984). 
Also, the cAMP-dependent protein kinase-induced phosphorylation of troponin I decreases 
Ca^"^ sensitivity of troponin C (McClellan and Winegrad, 1980 and Ray and England, 
1976). Thus, changes in the afSnity of the contractile elements for as well as the 
magnitude of the Ca^"^ transient achieved during a single beat can regulate the force 
development by a myocyte. 
3. Relaxation of the Ventricular Myocytes 
The decay of the transient (Fig. 3) occurs because of uptake of Ca^"^ into the 
SR mediated by the SR-Ca^"^ ATPase and extrusion of Ca^"^ from the myocyte primarily by 
the Na^-Ca^"^ exchange (Barry and Bridge, 1993). The SR Ca^"^-ATPase is concentrated in 
the longitudinal component of the SR (Jorgensen et al., 1982). Regulation of the SR Ca^"*"-
ATPase occvirs primarily by phosphorylation of phospholamban which binds to and 
inhibits Ca^"*" transport by the SR Ca '^^ -ATPase (Barry and Bridge, 1993). When 
pho^holamban is phosphorylated by cAMP-dqjendent protein kinase, the inhibition of SR 
Ca -ATPase by phospholamban is 
Fig. 3. Events associated with a fall in [Ca^^i and relaxation (Adapted from Barry 
and Bridge, Circulation, Vol. 87, 1993, page 1809). SR, sarcoplasmic 
reticulum; SL, sarcolemma. 
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removed, resulting in a greater for Ca^"*" transport (Sasaki et al., 1992). 
Ca^^ is bound to calsequestrine after uptake by the SR Ca^"^-ATPase (Barry and 
Bridge, 1993). Calsequestrine is the major Ca '^*"-binding protein in cardiac muscle. 
Binding and release of Ca by calsequestrine is thought to be important in excitation-
contraction coupling, but its exact role is not understood. 
Digoxin 
Introduction 
Digitalis glycosides were introduced into the clinical practice of medicine by 
William Withering two hundred years ago and they have been a major impetus to 
cardiovascular phamacologic research since then (Sonberg et al., 1985). The inotropic 
effect of digitalis in a cat right ventricular papillary muscle was demonstrated by Cattel and 
Gold (1940). Since then, digitalis has remained a major part of the therapeutic approach to 
patients in congestive heart failure (CHF) and atrial fibrillation. 
Digitalis glycosides have increased our understanding of cardiac cellular 
mechanisms involving contractility (Miura and Biedert, 1985). In the last fifty years many 
studies involving drug interactions, bioavailability, drug disposition, elimination, and 
clearance have had their origin in clinical problems relating to digitalis administration 
(Sonberg et al., 1985). 
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Cellular Mechanism of Digitalis Action 
Although digitalis glycosides, especially digoxin, have been used in the treatment of 
arrhythmia and congestive heart failure for over two hundred years, the mechanism of their 
positive inotropic action remains controversial. The most widely accepted mechanism is 
their well-known inhibitory effect on the Na"*", K"^-ATPase (pump) resulting in an increase 
in [Na"^]; leading to an increase in [Ca^^j through the Na"^ (out) /Ca^^ (in) exchange. 
Studies of the effects of digitalis on the electrophysiological properties of 
mammalian cardiac tissues have revealed a close relationship between digitalis and 
(Besch et al., 1970 and Ito et al., 1970). Since the cardiac glycosides inhibit the Na^, K^-
ATPase transport system, the loss of woiild result in a decrease of cellular 
transmembrane potential (Cranefield and Hoffinan, 1958 and Hoffinan and Singer, 1964). 
This would account for many of the observed electrophysiological effects of cardiac 
glycosides. Measurements of [K^]; activity have demonstrated that there is approximately a 
14% decrease in the value of activity that occurs concomitantly with a decrease in 
measured transmembrane potential due to cardiac glycoside exposure (Miura and co­
workers, 1976 and 1977). Using a recessed-tip, Na"^ -sensitive glass microelectrode, it has 
been demonstrated that the [Na"^; was 7.2 mM at normal [Na'^ Jo for sheep heart purkinje 
fibers but application of a cardiac glycoside to the perfusate produced a rise in [Na^]; that 
was only slowly reversible (Ellis, 1977). 
4. Schematic illiistration of the cellular mechanism of the action of digoxin. 
Digoxin inhibits Na^, K^-ATPase causing an increase in [Na"^ ];. Increased 
[Na"^]; causes an increase in [Ca^^]-, by increasing Ca^^ influx on the Na^ -
exchanger during the excitation contraction coupling of cardiac 
muscle. Increased [Ca^^ Jj provides more Cs?* that is available for -
2"^* 2+ induced Ca release and thus an enhanced Ca transient and positive 
inotropic effect 
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Measurements of Na^ and Ca^^ across the cell membrane were linked by the Na"^ -
Ca^"^ exchange mechanism. An increase in Ca^"^ influx associated with an increase in [Na^]i 
could accovint for a positive inotropic effect in cardiac tissue after inhibition of monovalent 
cation active transport (Baker et al., 1969). These data support the hypothesis that 
inhibition of monovalent cation active transport by cardiac glycosides is causally related to 
the development of their positive inotropic effect on heart muscle. 
Modem theories have suggested a greater role of [Ca^"*" ]; in autoregulation (Marban 
and Tsien, 1982). There might be a regulation of Ca^"^ entry itself by a -facilitated 
mechanism that might amplify the digitalis glycoside effect of positive inotropy (Miura and 
Biedert, 1983). These theories suggest a far more complex role of the cardiac glycosides 
than just inhibition of the monovalent cation transport mechanism. This role may include 
biochemical intracellular feedback mechanisms that could autoregulate mtracellular cation 
movements. 
The cardiac glycosides bind to an alpha subunit of the Na^, -ATPase and inhibit 
the translocation of Na^ and K"^. Thus, partial inhibition of the Na'^  pump in the 
sarcolemma of the myocyte by cardiac glycosides causes a slight rise in [Na^]j and a slight 
fall in An increase in [Na^; would be expected to increase the influx of Ca^"' on the 
Na^-Ca^"*" exchanger initially during the action potential and to impair extrusion of Ca^"*" by 
the Na"^ -Ca^^ exchange subsequently during the Ca^"^ transient Both of these effects 
would be expected to cause the observed increase in diastolic [Ca^^Ji and the increased 
loading of the SR with Ca^^ also providing more Ca^"^ available for Ca^^-induced Ca^"^ 
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2+ 
release and thus an enhanced Ca transient and a positive inotropic effect (Barry and 
Bridge, 1993). The cellular mechanism of action of digoxin is schematically illustrated in 
Fig. 4. 
Many of the effects of digoxin on the electrical and mechanical activity of the heart 
result from glycoside-induced modification of both automatic neural activity and the 
sensitivity of the heart to the vagal and sympathetic neurotransmitters (Hoffman and 
Bigger, 1990). Digoxin increases the vagal activity and decreases the sympathetic activity. 
The increase in vegal activity caused by digoxin appears to result from effects at several 
sites in the nervous system. The atrial baroreceptors are sensitized, probably because of an 
effect of digoxin on active transport of cations in the afferent nerve terminals. Digoxin also 
increases the sensitivity of the sinus node to the negative chronotropic effect of 
acetylcholine (Hoffinan and Bigger, 1990). 
Digoxin reduces the sensitivity of the sinoatrial and atrioventricular nodes to 
catecholamines. If the sinus rate is increased, as in CHF, the negative chronotropic effect 
of digitalis is usually quite prominent. Inhibition in the sympathetic activity by digoxin 
contributes to the net effect The atrioventricular node is strongly influenced by the indirect 
action of digoxin. The enhanced vegal activity and the decrease in sensitivity to the 
catecholamines have pronounced effects on both the generation of the atrioventricular 
nodal action potential and the transmission of impulses through the node. Acetylcholine 
decreases the rate of rise and amplitude of action potentials at these sites. The impairment 
of conduction may progress to complete heart block (Hoffinan and Bigger, 1990). The 
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most important result is to diminish the rate at which atrial impulses can be transmitted to 
the ventricles. Thus, in atrial tachycardias, atrial flutter, and atrial fibrillation, 
administration of digoxin will decrease the ventricular rate because of a blockage of an 
increased fraction of atrial impulses in the atrioventricular junction. 
Clinical use of Digitalis 
Digitalis glycosides, primarily digoxin are widely used in modem medicine for the 
control of the ventricular response in atrial fibrillation and the treatment of CHF. Recently, 
the use of digoxin for the treatment of CHF in patients with normal sinus rhythm has 
become quite controversial. Several studies suggest a small but definite hemodynamic or 
clinical improvement in patients treated with digoxin. These effects are limited by the 
onset of toxicity, which is at least partially mediated via the central nervous system (CNS). 
If the inotropic effect of the drug could be separated from the CNS effect, much higher 
doses of digitalis could be used and presumably a greater therapeutic effect could be 
obtained (Levitt and Keefe, 1985). 
Gheorghiade and Beller (1983) studied 24 patients with ischemic heart disease, 
CHF and normal sinus rhythm. Eighty-eight percent of those patients were also taking a 
diuretic or a vasodilator. Withdrawal of digoxin from the regimen of these patients did not 
influence their heart rate, arterial pressure, weight, or ejection fraction. The data suggested 
that the withdrawal of digitalis failed to worsen the clinical manifestation of CHF in these 
patients. 
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Davidson and Gibson (1973) studied the effect of digoxin in CHF patients with 
normal sinus rhythm. They found a positive inotropic effect on the initial administration of 
digoxin but they were not able to demonstrate this effect with long-term administration. 
Since, this initial effect was less than that produced by mild exercise one question is not 
whether digitalis has an effect, but whether the effect in patients with normal sinus rhythm 
is clinically meaningful. 
Lee and Dagostino (1982) studied 25 patients who were in normal sinus rhythm 
with CHF. In slightly more than half of the patients, the severity of CHF was reduced by 
digoxirL Responders, individuals whose CHF was improved by digoxin, had more chronic 
and more severe CHF, greater left ventricular dilation, and lower ejection fractions. The 
presence of a third heart sound (third heart sound due to rapid ventricular filling) was cited 
by the author as an important predictor of whether patients would respond to digitalis. 
About half of the patients who were in normal sinus rhythm responded clinically to 
digitalis. 
Mechanism of Digitalis Toxicity 
The molecular mechanism of digitalis toxicity is the same as that for its therapeutic 
action, just at a more intense level. Binding of digitalis glycosides to a large fraction of the 
sarcolemmal Na^ -ATPase molecules leads to a marked decrease in the activity of the 
Na^-K^ exchange pump across the cell surface. As a result, [Na^ ]; and [K^ ]„ increase. The 
increased [Na^j causes an increase in Na^-Ca^"^ exchange, raising the [Ca^"^;. The 
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increased [Ca^^]; is buffered in the usual intracellular storage sites to a point where 
ultimately, in marked cardiac glycoside toxicity, the [Ca^"^]-, increases (Bigger, 1985). 
Monensin 
Introduction 
lonophores carry ions across lipid barriers as complexes soluble in the lipid phase of 
membranes. The potential use of ionophores as probes of biological fimction, or as 
potential therapeutic agents, was recognized very early, but major economic importance 
was not forthcoming until the discovery of monensin in 1967 (Mollenhauer et al., 1990). 
Initially, Shumard and Callender (1969) recognized the effectiveness of monensin 
ag^nst experimental infections of coccidia in chickens and subsequently it was used widely 
in birds for control of coccidiosis. Monensin is also efficacious in the control of 
coccidiosis in lambs and calves (Bergstrom and Maki, 1978 and Fit^erald, 1973). In beef 
cattle it improves the feed efficiency by 10-15% due to an increase in the production of 
more propionic acid which yields more energy than acetic or butyric acids following 
ruminant fermentation (Richardson et al., 1974). 
Of the more than one hundred ionophores that have been reported, three, monensin, 
lasalocid, and salinomycin, have wide spread commercial use and of these, licensed 
monensin is probably used most widely (Mollenhauer et al., 1990). Among the domestic 
animals, horses are most sensitive to monensin toxicity (Whitiock et al., 1978). If 
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monensin is used as a coccidiostat or growth promoter in other species, the drug-treated 
feed would be dangerous if accidentally consumed. The medial lethal single dose (LD50) of 
monensin in horses is 2-3 mg / kg body weight (Mitema et al., 1988). The clinical signs of 
monensin toxicity in animals include anorexia, ataxia, lethargy, diarrhea, and paresis (Van 
Vleet et al., 1983). 
Cellular Mechanism of Monensin Action 
One of the original interests in ionophores was their perceived potential for directly 
modifying intracellular ionic gradient, particularly Ca^"^, which would lead, hopefully, to 
the development of useful pharmacological agents or, alternatively, provide a tool for 
studying cellular functions mediated by changes in [Ca^"^;. It was soon realized, however, 
that many of the inotropic effects of the divalent ionophores could be duplicated with even 
greater efficiency by monovalent ionophores such as monensin which complexes Na^ but 
almost no Ca^^ (Mollenhauer et al., 1990). 
Monensin is a monovalent polyether antibiotic in which the oxygen functions are 
concentrated at the center of the structure where they are available for the complexation of 
a suitable cation, in this case Na^. The alkyl groups are spread over the outer surface 
rendering the complex lipid soluble thus allowing the antibiotic to enter and diffuse through 
biological membranes. It is an open chain molecule that is capable of ion complexation 
through a cyclic form stabilized by hydrogen bonding between the carboxyl and hydroxyl 
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groups. Monensin mediates aNa* (in)/H^ (out) exchange due to its affinity for Na^ 
(Mollenhauer et al., 1990). 
Once the ion transverses the membrane as a monensin-Na^ complex, Na"^ is 
released, and the monensin molecule attracts a to form an undissociated molecule which 
can retraverse the membrane to release the KT to the outside of the cell, vesicle, organelle, 
or other subcellular compartment. Thus, the net effect for monensin is a transmembrane 
exchange (Fig. 5) of monovalent ions for protons (Mollenhauer et al., 1990). 
Effects of ionophores on cation-transport and their distribution among different 
membrane-bounded compartments within the cell, will vary depending on the physical and 
chemical properties of the different membranes. Membrane fluidity, thickness, curvature, 
change and orientation of polar head groups of phospholipids, cholesterol content, and 
protein content, all influence solubility, penetration, and expression of the ionophore. The 
pharmacological effects of monensin will depend on the membrane composition and 
functional characteristics of the different compartments involved (Mollenhauer et al., 
1990). 
In cardiac tissue, monensin transports Na^ across the sarcoplasmic membrane into 
the cytosol, hereby increasing [Ca^^]; via a Na^-Ca^"^ exchange mechanisms (Gaide et al., 
1984 and Sutko et al., 1977). An increase in [Ca^"^ ]; affects permeability, leading to 
shortening of the action potential (Isenberg, 1975). These results showed that, the 
increase in increases conductance in cardiac tissue (Kass and Tsien, 1976 and 
McGuigan and Bassingthwaighte, 1974) through Ca '^*'-activated K"^ channels. 
Fig. 5. Schematic illustration of the cellular mechanism of action of monensin. 
Monensin binds Na^ outside the myocyte and carries it into the cytosol. 
Inside the cell, monensin releases the Na* and binds a ET and carries it to 
the outside of the myocyte. The net effect is an increase in [NV]; and pH;. 
Elevated [Na^j increases the [Ca^"^; via the Na^ -Ca^"*" exchanger during the 
excitation contraction coupling. Both increased [Ca^"*!; and pHj cause the 
positive inotropic action of monensin. 
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Monensin increases the resting tension in canine cardiac purkinje fibers and the 
tension developed decreases in Tyrodes solution with an increase in to 4.5 mM. This 
is due to a overload probably related to the high [Ca^^]o (Tsuchida and Otomo, 1990). 
The most characteristic changes in the action potential elicited by monensin in canine 
purkinje fibers are the shortening of the duration and the suppression of automaticity. On 
the other hand, monensin does not significantly affect the action potential parameters, 
either in the -free solution or in the Na^ -free solutions. Therefore, either extracellular 
Na* or Ca^^ is necessary for monensin to exert its effects on the action potential (Tsuchida 
and Otomo, 1990). 
In 1989, Hugtenburg et al., studied the differential effect of Ca^"*" channel 
antagonists on the positive inotropic effects induced by Ca^"*^ and monensin in cardiac 
preparations of rats and guinea-pigs. They foxmd that monensin did not change the basal 
force of contraction in rat p^illary muscle but it increased the force of contraction in 
guinea-pig papillary muscle. This difference indicates that the utilization of Ca^"^ in rat and 
guinea-pig myocardium is different. They also used nifedipine which is an L-type Ca^"*" 
channel blocker and ryanodine which is a ryanodine receptor blocker. They foimd that the 
positive inotropic effect of monensin in guinea-pig papillary muscles speared nearly 
insensitive to iiihibition by nifedipine and was only partially blocked by ryanodine. They 
concluded that monensin-generated Ca^"^ may be through the Ca '^^ -induced Ca^"^ release 
mechanism. 
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In 1984, Ozaki et al., studied the action of monensin on smooth muscle of guinea-
pig aorta. They found that monensin induced a contraction in isolated guinea-pig aorta in 
normal K"^ (5.4 mM) solution. They also observed that the monensin-induced contraction 
was markedly inhibited by a-adrenoceptor antagonists phentolamine (10'^  M) or prazosin 
(10"^ M). They concluded that the monensin-induced contraction resulted from the release 
of norepinephrine from the nerve endings. 
Toxicity Studies of Monensin 
The mechanism by which monensin interacts with coccidia and rumen microflora is 
well documented (Mollenhauer et al., 1990). However, the interaction between monensin 
and the tissue of the host animal is less well understood even though the clinical 
manifestations of monensin poisoning are well known. When used at recommended levels, 
either as a coccidiostat or a growth promoter, monensin seldom causes poisoning. Misuse 
of the product, usually from improperly mixed feed, may cause toxicosis and death. 
Horses, ponies and other equine species are particularly sensitive to monensin poisoning. 
In manmials, the physical signs of monensin toxicosis commonly include anorexia, 
diarrhea, depression, sweating, ataxia, palpitations of the heart, sudden death following 
exercise (Mollenhauer et al., 1990). Stiffiiess of hindquarters and swollen gluteus muscles, 
elevated pulse rate, and electrocardiograph abnormalities also have been reported 
(Mollenhauer et al., 1990). The most consistent microscopic observation in ponies, cattle. 
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pigs and fowl is cardiac myocyte degeneration and vacuolization (Mollenhauer et al., 
1990). 
A differential effect of monensin was noted by Van VIeet and Ferrans, 1983 who 
observed in swine severe necrosis in the diaphragm, vastus lateralis, semitendinosus, 
triceps and intercostal muscles; moderate necrosis in longissimus lomburum muscle; and 
little necrosis in the tongue. Necrosis was the greatest in muscles containing a high portion 
of Tj'pe 1 fibers. Monensin toxicosis in swine provides a unique example of acute drug-
induced myotoxicity that is accompanied by rapid and complete regeneration of the 
widespread necrosis of skeletal muscle and the biochemical pathogenesis of monensin-
induced myotoxicity is presumed to result from Ca overloading. 
Swollen mitochondria (a characteristic response to monensin) have not been 
observed in any of the nonmuscle cells of the heart, diaphragm, or appendicular tissues or 
in liver, adrenal or kidney cells (Mollenhauer et al., 1990). Thus, it appears that monensin 
administered to mammals invivo tends to induce mitochondrial changes only in selected 
tissues and / or types of muscle fibers. The mechanisms for these mitochondrial changes 
and reasons for specificity are not known. 
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FUNCTIONAL CHANGES IN ISOLATED GUINEA-PIG PAPILLARY MUSCLE 
INDUCED BY MONENSIN AND DIGOXIN 
A paper to be submitted to the Journal of Action and Agents 
Ismail Meral, Frederick B. Hembrough, Theodore B. Bailey, and Walter H. Hsu 
Abstract 
We investigated four different concentrations of digoxin (0.3,1,3 and 10 junol/1) 
and three different concentrations of monensin (2,7 and 12 |amol/l) on the contraction force 
of guinea-pig papillary muscles. The highest increase in contraction force was obtained by 
using 3 |imol/l digoxin or 7 ^mol/1 monensin. These concentrations were chosen for 
subsequent experiments to study the effects of these drugs on contraction force (CF), initial 
contraction velocity (ICV), averse contraction velocity (ACV), initial relaxation velocity 
(IRV) and stimulus to response time (ST) change in fatigued (defined as the level at which 
papillary muscle contraction had lost 30% of its original contraction force with the elapse 
of time) and non-fatigued guinea-pig papillary muscles. The five hours of measurement in 
Experiment 3 were divided into five periods (TO was equilibration, Tl, T2, T3, and T4 
were respectively one, two, three, and four hours after drug administration). We found that 
both monensin and digoxin increased the CF and ACV at Tl and increased the IRV at T2. 
Digoxin lost its effect with the elapse of time while monensin did not Digoxin also 
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increased the ICV at T1 and decreased the ST at T2, T3 and T4. However, monensin 
increased the ICV at T4 and did not change the ST. We also found that although fatigued 
and non-fatigued guinea-pig papillary muscles behaved differently during four hours of 
experimentation, they did not respond to the drug treatment differently. We concluded that 
the initial effects of these two drugs on guinea-pig papillary muscles are similar regarding 
contractility but in time digoxin loses its positive inotropic effect while monensin does not. 
Thus, monensin should be studied further to determine if it is useful in the treatment of 
congestive heart failure 
Introduction 
Monensin is a carboxylic ionophore antibiotic which is derived from the 
fermentation of the fimgus Streptomyces cinnemonensis [1]. It is used as a coccidiostat in 
birds, lambs and calves [2,3,7] and primarily as a growth promoter [4,5] and as a bloat 
preventive [3,6] in cattle. The biochemical pathogenesis of monensin-induced myotoxicity 
has been shown to be caused by intracellular calcium overloading, especially in 
mitochondria [S]. 
Monensin has a strong positive inotropic affect in cardiac muscle [9,10, 11]. This 
effect occurs because, as an ionophore, monensin has strong affinity for [Na'^ jg. The 
afBnity of monensin for Na^ is ten times Ihat for K"^, its nearest competitor in biological 
systems [8]. The monensin-induced increase in [Na'^ ]; facilitates the entry of Ca^"^ into the 
cell by a Na"^ (out) / C?l* (in) exchange mechanism [12]. This Ca^"^ shift is the primary 
36 
factor mediating the cellular response. Another factor modifying the cellular response 
includes the alteration of the pH of intracellular components (pHj) since monensin increases 
the pHj by transferring HT out of the cell [8]. 
Digitalis glycosides, including digoxin, have been used in the treatment of 
arrhythmia and heart failure for over 200 years [13]. Although cardiac glycosides augment 
contraction in the isolated heart or muscle preparations their effect in the normal 
mammalian heart remains in dispute. The inotropic action of digoxin in the myocardium 
depends on an inhibition of Mg^^-dependent Na^, -ATPase which is necessary for the 
Na"*" (out) / (in) exchange. Increased [Na^]; leads to an increase in by a Na"^ (out) 
/ Ca^"^ (in) exchange mechanism and thus, increases force of contraction [14,15]. 
In the present study, we compared the positive inotropic actions of digoxin and 
monensin over a four-hour experimental period. Many pharmacological experiments have 
compared different drugs according to their initial effects. Treatment of papillary muscles 
with these drugs for four hours gave us a better understanding of the effects of these two 
drugs with time. In the present experiment, we also compared non-fatigued (fresh) 
papillary muscles to "fatigued (tired) papillary muscles". "Fatigued muscles" had lost 30% 
of their original contraction force with the elapse of time before they were treated. It has 
been suggested that if the capacity of heart muscle to develop force is severely depressed, 
the inotropic action of digoxin is much larger than would occur in normal muscle [27]. 
This rationale suggested that the effects of these two drugs may be different on fatigued 
muscle when compared with non-fatigued muscle. 
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The objectives of this experiment were to utilize a papillary muscle preparation to 
compare monensin with digoxin using a fresh preparation and a preparation undergoing 
fatigue, and to establish the need for further investigation of monensin for the possibility of 
using it in the management of certain clinical syndromes such as congestive heart failure 
(CHF). 
Materials and Methods 
Preparation of Papillary Muscles 
Thirty male guinea-pigs, 500-600 g, were heparinized (1000 lU per animal, IP 
injection) 30 minutes before being decapitated. One animal was used per day. Hearts were 
removed rapidly and put in a beaker filled with ice-cold KRB of the following composition 
[mmol/1]: Na^ 115.9: 2.2: 4.0: Mg^^ 1.3: CI", 126.9: H2P04', 2.1: HCO3', 21.7: 
glucose, 10.9. The pericardium was removed, and the aorta and the pulmonary artery were 
excised. The hearts were transferred to a second beaker of the same solution, and then 
rapidly put in a glass pan filled with Krebs solution and bubbled with 100 % O2. Two 
papillary muscles with diameters of approximately 1.0-1.5 mm were dissected from the 
right ventricle of each guinea-pig and each muscle was mounted in an organ bath 
containing a Krebs solution with 2.2 mmol/1 CaCl2. The Krebs solution was perfused with 
a mixture of 95 % O2 and 5 % CO2 and maintained at 37 °C. The pH was maintained 
between 7.50 - 7.60. The muscles were attached to a capacitance transducer (Harvard 
isometric capacitance transducer. Harvard apparatus, inc.. South Notick, MA) electrically 
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connected to a Beckman recorder (R611). The tendon end of each muscle was attached to 
the transducer by a silk suture and the opposite end was held by a plastic clamp placed in 
the muscle chamber. Muscles were stimulated at a jfrequency of 0.2 PPS by using a pair of 
platinum field effect electrodes. The transducers to measure force were calibrated for each 
experiment by using weights (1 g equaled a displacement of 40 mm). Frequency was 
calibrated by an oscilloscope. 
Experiment 1: Effect of digoxin on the contraction amplitude of guinea-pig papillary 
muscle (Fig. 1) 
A stock solution of 1.5 mmol/1 digoxin (Sigma Chemical Co., St. Louis, MO) 
prepared with alcohol was used. Five treatments were used; control (0.18% alcohol), and 
digoxin at 0.3,1,3 and 10 jimol/l. Each treatment was replicated four times. Treatments 
were administered after an equilibration period of 35 min. Contraction force was measured 
one hour after treatment because the highest contraction force was obtained one hour after 
digoxin administration. 
Experiment 2: Effect of monensin on the contraction amplitude of guinea-pig papillcay 
muscle (Fig. 2) 
A stock solution of 3.5 mmol/1 monensin (Sigma Chemical Co., St. Louis, MO) 
prepared with alcohol was used. Four treatments were used; control (0.18% alcohol), and 
monensin at 2,7 and 12 ^molA. Treatments were administered after an equilibration period 
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of 35 min. Contraction force was measured two hours after treatment. Unlike the digoxin 
experiment, the highest force was obtained two hours after monensin administration. 
Experiment 3: Contractility Experiment 
Sixty papillary muscles were obtained from 30 guinea-pigs as described in the 
preceding section. Two dififerent treatments were used on the same day on two different 
papillary muscles obtained from one guinea pig. With non-fatigued muscles, chemicals 
were administered to the organ bath after an equilibration period of approximately 35 min. 
With fatigued muscles, chemicals were administered to the organ bath after a fatigue period 
which was defined as the level at which papillary muscle contraction had lost 30% of its 
original contraction force with the elapse of time. Data were obtained from each muscle 
five times (before treatment application and 1,2,3, and, 4 hours after continuos treatment). 
Variables measiired at each period included contraction amplitude, contraction angle, 
relaxation angle and stimulus to response time. Contraction force (CF), initial contraction 
velocity (ICV), average contraction velocity (ACV), initial relaxation velocity (IRV) and 
stimulus to response time (ST) were calculated as fionctions of the measured variables. 
Because there was no significant difference between fatigued and non-fatigued guinea-pig 
papillary muscles to the drug treatment over time, data obtained from fatigued and non-
fatigued papillaiy muscles were combined. 
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Treatment design, experimental design and statistical analysis 
Six treatments were used in this study (Table 1. shows the treatment mean ± 
standard deviation of the mean). Treatments corresponded to a 2 by 3 factorial with 2 
methods and 3 drugs. Doses used were based on the results of the previous two 
experiments. 
Treatment Drug Method 
1 Control Non-fatigued 
2 Control Fatigued 
3 Digoxin Non-fatigued 
4 Digoxin Fatigued 
5 Monensin Non-fatigued 
6 Monensin Fatigued 
Because of the large variability among animals, a balanced incomplete block design 
was selected as the experimental design. Each animal provided two muscles, individual 
muscles were the experimental unit for the experiment. Blocks were size of two; with each 
block containing two muscles from the same animal. Experimental units (a single muscle) 
were randomly allocated to treatments [see appendix]. Two replications of the basic 
incomplete block design were completed. Analyses of variance were obtained using PROC 
MDCED of SAS (SAS institute. Inc., 1988, release 6.03, Gary, NC). Fixed efifects in the 
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model included drug, method, time, the three two-factor interactions and the three factor 
interaction drug by method by time. Random effects in the model were block and block by 
treatment Unbiased estimates of treatment means and their errors were obtained using the 
LSMEANS statement The ANOVA indicated a significance when P < 0.05 [see appendix 
for ANOVA tables]. Contrasts [30] were used to test differences among means [see 
appendix]. 
Results 
Dose response of digoxin and monensin 
The effect of four different concentrations of digoxin on the contraction amplitude 
of guinea-pig papillary muscle is shown in Fig. 1. Three nmoI/1 digoxin caused the 
highest increase in contraction amplitude (contraction force). Fig 2 shows the effect of 
three different concentrations of monensin on the contraction amplitude of guinea-pig 
papillary muscle. Seven nmol/1 monensin caused the highest increase in contraction 
amplitude (contraction force). 
Effects of monensin and digoxin on contraction force, initial contraction velocity, average 
contraction velocity, initial relaxation velocity and stimulus to response changes of guinea-
pig papillary muscles 
Fig. 3 shows the changes in CF of guinea-pig papillary muscles during five time 
periods of the experiment Digoxin caused a positive inotropic effect in guinea-pig 
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papillary muscles at Tl. However, digoxin lost its positive inotropic action with the elapse 
of time and caused a negative rather than a positive inotropic action at T3 and T4. 
Monensin also caused a positive inotropic effect in guinea-pig papillary muscles at Tl. 
However, monensin did not lose its positive inotropic action up to T4. 
Fig. 4 shows the changes in the ICV of guinea-pig papillary muscles during five 
time periods of the experiment. Digoxin increased the ICV of guinea-pig papillary muscles 
at Tl and monensin increased the ICV at T4. Digoxin lost its effect between T2 and T4. 
Fig. 5 shows the changes in the ACV of guinea-pig papillary muscles during five 
time periods of the experiment Both monensin and digoxin increased the ACV of guinea-
pig papillary muscles at Tl. Digoxin lost its effect at T2 and T3 and decreased the ACV at 
T4. Monensin did not lose its positive effect up to T4. 
Fig. 6 shows the changes in the IRV of guinea-pig papillary muscles during five 
tune periods of the experiment Both monensin and digoxin increased the IRV of guinea-
pig papillary muscles at T2. Digoxin lost its effect at T3 and T4. However, monensin did 
not lose its positive effect up to T4. 
Fig. 7 shows the changes in the ST of guinea-pig papillary muscles during five 
time periods of the experiment Digoxin decreased the ST at 12, T3 and T4. However, 
monensin did not change the ST at any time period. 
Fig. 8 shows the representative tracing of the monensin- or digoxin-induced 
changes in the CF of guinea-pig papillary muscles. Digoxin produced after-contractions 
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Starting at T2. After-contractions and decrease in the positive inotropic effect of digoxin 
occurred at the same time. Monensin did not produce after-contractions with time. 
Although fatigued and non-fatigued guinea-pig papillary muscles behaved 
differently during four hours of experimentation, they did not respond to the drug treatment 
differently over time. 
Discussion 
Effects of monensin and digoxin on contraction force, initial contraction velocity, average 
contraction velocity, initial relaxation velocity and stimulus to response change of guinea-
pig papillary muscle 
This study was undertaken to deteimine whether monensin and digoxin had the 
same effect on guinea-pig papillary muscles regarding contraction force, rate of contraction 
and relaxation and stimulus to response time. Because the contraction of heart muscle is 
affected by many factors, such as, pH;, interaction of actin-myosin, changes in ionic 
concentration, this experiment, like many others, produced more questions than answers. 
Contractility is the performance of a heart at a given preload and afterload. An 
increase in contractility (positive inotropic effect) is not only reflected by increments in 
developed force but also reflected by increments in velocity. Digitalis glycosides increase 
the contractile state of the myocardixrai by shifting the force-velocity relation upward and to 
the right in htmian subject [14]. 
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The positive inotropic action of digoxin is due to the inhibition of Na"^, K'^ -ATPase. 
As a result, there is a gradual increase in [Na^]; and a gradual and small decrease in [K^]; 
[16,17]. An increase in [Na^jj by digoxin increases the [Ca^"^]i due to the entry of Ca^"^ 
into the cell by the Na"^ (out) / Ca^"^ (in) exchange [18]. Increased [Ca^"^]; causes the release 
of additional Ca^* from the SR [19] and, thus enhances the contractility. The Na'^ -HT 
exchange also appears to play a role in amplifying the increase in [Ca^"^]j that results from 
inhibition of the Na^, K'^ -ATPase. The increase in [Na^]; causes a fall in pH,, as protons are 
exchanged for [Na^]i to compensate for decreasing the increased [Na^]; [20]. 
In our experiment we were able to demonstrate the positive inotropic effect of 
digoxin in guinea-pig papillary muscles. Digoxin's positive inotropic effect occurred 
gradually. It took 60 min to obtain a positive inotropic effect with digoxin treatment. Our 
result is consistent with that of Taubert and colleagues [24] who demonstrated a positive 
inotropic effect in cat papillary muscles by using 2 |amol/l digoxin over 110 min. We also 
demonstrated that continuous treatment of a papillary muscle with digoxin eliminated the 
positive inotropic action of digoxin. This is the first in vitro experiment that examined the 
action of digoxin on guinea-pig papillary muscle for four hours after treatment and 
demonstrated a decrease in digoxin induced positive inotropy with the elapse of time. Wier 
and Hess [25] have suggested that the negative inotropic effect of high concentrations of 
digoxin (> 10 jmiol/l) may be related to lowering of pH; [by a Na^ (out)/Kr (in) 
mechanism] which would decrease the affinity of the myofilaments for Ce?*. However, the 
contraction of digoxin in our experiment was lower than 10 jimol/1. Our results indicated 
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that even a lower concentration of digoxin (3 }imol/l) may cause a negative rather than a 
positive effect with the elapse of time probably due to a decreased pH;. 
The 7 ^unol/l monensin administration increased the CF of guinea-pig papillary 
muscles at T1 (60 min after treatment). Unlike digoxin, monensin did not lose its positive 
inotropic effect on gumea-pig papillary muscles with the elapse of time. This demonstrated 
that the positive inotropic effect that was obtained with monensin treatment lasted longer 
than digoxin. Monensin binds Na"^ outside of the cell and carries it into the cell and 
I 2^ increases [Na ]; and thus [Ca ]; [8]. Monensin also increases the pH; due to the increased 
exit of a when monensin is transported out of the cell [8]. 
The action of these two drugs rely on an increase in [Ca^^Jj due to an increased 
[Na"^i. However, the mechanism is different Although a Ca^^ shift is the primary factor 
mediating the cellular response of these two drugs, another factor modifying the cellular 
response is the pH-, change. Contraction of the heart is pH sensitive; classically an acidosis 
reduces contractions by inhibiting the Na^-Ca^^ exchange [22,23], whereas an alkalosis 
increases contractions by stimulating Na^-Ca^"^ exchange and the release of Ca^"^ from the 
SR [21]. Digoxin induces an increase in [Ka^]; which in turn causes a fall in pH;, as 
protons are exchanged for intracellular Na^ to lower the increased [Na^-, [20]. 
To be able to demonstrate whether digoxin- or monensin-induced increase in [Ca^"^]; 
is due to an influx or a release from the SR, we measured the ICV and the ACV. There are 
two components, early (PI) and the late (P2) components, of guinea-pig papillary muscle 
contraction wave [28]. The PI is suggested to be generated by Ca^"*" released from SR 
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whereas P2 is thought to result from Ca^"^ influx [28]. The ICV would be affected by the 
change in PI and the ACV would be affected by those factors that produce both PI and P2 
of the contraction wave [29]. An increase in the rate of Ca^"^ release from the SR would 
increase the ICV. It has been demonstrated that 3 and 10 |jmol/l digoxin strongly enhanced 
PI which overlapped P2 [26]. When PI is inhibited by using a -free solution, digoxin 
exerts only a negative inotropic effect [29]. Thus, in agreement with Adamantidis et cd., 
[26], the positive inotropic effect of digoxin is thought to be mediated by an increase in 
activator Ca which enters the cell and causes the release of Ca from the SR. Digoxin 
increased the ICV of guinea-pig papillary muscles at T1 and monensin increased the ICV at 
T4. Digoxin lost its effect with the elapse of time. This finding suggested that both 
digoxin and monensin increase the rate of Ca release from the SR in guinea pig papillary 
muscles. However, digoxin lost its effect with time probably due to a decreased pH;. 
The ACV is not only influenced by the rate of Ca^"^ release from the SR but also it is 
influenced by the Ca mflux, number of functional cross-bridges and affinity of troponin C 
for Ca^"^ [29]. An increase in Ca^"^ release from the SR woxild increase ACV by allowing 
increased binding of Ca to the contractile proteins and by increasing ATPase activity of 
myosin [14]. When Ca^^ binds to troponin C, in an isotonic contraction, a conformational 
change is induced that results in the interaction of actin and myosin, with the cross-bridge 
interaction and contractile element shortening [14]. Both monensin and digoxin increased 
the average contraction velocity of guinea-pig p^illary muscles at T1. Digoxin lost its 
effect with the elapse of time while monensin did not This clearly indicated both digoxin 
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and monensin have a significant effect on the rate of Ca release from the SR, the affinity 
of troponin C for Ca^"^ or myosin-ATPase activity. However, digoxin had an inhibitory 
effect at T4 which could be due to a decrease in pHj that inhibits the affinity of troponin C 
forCa^^[23]. 
The IRV is affected by two mechanisms. First, a SR Ca '^^ -ATPase that pumps 
into the SR thus decreases [Ca^"^];. Second, a Na^ (in) / Ca^"^ (out) exchange [14]. Under 
steady-state conditions, the amount of Ca^"^ entering the cell equals that which exits the cell, 
and the amount released by the SR equals that sequestered by the SR [14]. If an abrupt 
change in this balance of fluxes takes place, then the content of the SR will be 
affected. Both monensin and digoxin increased the IRV of guinea-pig papillary muscles at 
T2. Digoxin lost its effect with the elapse of time while monensin did not This increase in 
IRV was due to the SR Ca^^-ATPase and the Na"^ (in) / (out) exchange which would 
be stimulated when [Ca^"^]; increased in order to lower the increased [Ca^"^]-,. 
Monensin did not change the ST at any time period. However, digoxin decreased 
the ST at T2, T3 and T4. This indicated that papillary muscles that were treated with 
digoxin became more sensitive to the electrical stimulus. This indicated that voltage 
dependent Ca '^^ -channels and voltage dependent Na"^-channels would become more 
sensitive and open earlier in muscles treated with digoxin. 
The toxic effect (after-contractions) of digoxin was noted [31] at high doses (> 10 
|imol/l) is due to an increase in [Ca^"^;. These after-contractions are produced by an 
oscillatory release of Ca^"^ fiom SR by a Ca '^^ -induced release mechanism [32] and can 
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be reversed by the addition of a Ca^~ channel blocking agent [31]. The concentration of 
digoxin (3 ^imol/l) in our experiment was lower than 10 [imol/1. However, our result 
indicated that even lower concentration of digoxin may produce a toxic effect on guinea-
pig papillary muscles with a long term treatment Unlike digoxin, monensin did not 
produce a toxic effect with time. However, more studies are needed to evaluate the effect 
of monensin on living animals. 
We concluded that although fatigued and non-fatigued muscles acted differently 
over time, they did not respond to the drugs differently. However, if fatigue was increased 
to 50%, instead of 30%, these papillary muscles might have responded to drug treatment 
differently than non-fatigued papillary muscles. More importantly the treatment with 
monensin demonstrated that the positive inotropic effects lasted longer than with digoxin 
treatment. This was also true for the effect of monensin on the average contraction velocity 
which was long lasting as well as being a potent positive inotrope. This increased 
contraction velocity, as compared to both the control and the digoxin treated papillary 
muscles, is important; as an increased contraction velocity acts as an decreased afterload to 
a functional heart and can be an important contributor to heart failure. 
References 
[1] M. E. Jr. Haney, and M. M. Hoehn, Monensin, a new biologically active compound: 
1. Discovery and isolations. Antimicrob. Agents Chemother. 349-352 (1967). 
[2] M. Fahim, and B. Pressman, Cardiovascular effects and pharmacokinetics of the 
carboxylic ionophore monensin in dogs and rabbits. Life Sci. 2P, 1959-1966 (1981). 
[3] J. F. Van Vleet, and V. J. Ferrans, Ultrasonic alterations in skeletal muscle of pigs 
with acute monensin rr^otoxicosis. Am. J. Pathol. 114(3), A6\A1\ (1984). 
[4] T. H. Elsasser, Potential interactions of ionophore drugs with divalent cations and 
theirficnction in the animal body. J. Anim. Sci. 59^3^, 845-853 (1984). 
[5] J. H. Thornton, F. N. Owens, R. P. Lemenager, and R. Tatusek, Monensin and 
rumirumt methane production. J. Anim. Sci. 45, 336 (Abstr) (1976). 
[6] E. L. Potter, C. O. Cooley, L. F. Richard, A. P. Roim, and R. P. Rathmacher, Effect of 
monensin on performance of cattle fed for age. J. Anim. Sci. 43,665-669 (1976) 
[7] E. S. Mitema, and S. Sangiah, Effects of some calcium modulators on monensin 
toxicity. Vet. Hum. Toxicol. 30(5), 409-413 (1988). 
[8] H. H. Mollenhauer, D. J. Morre, and L. D. Rowe, Alteration of intracellular traffic by 
monensin; mechanism, specificity and relationship to toxicity. Biochim. Biophys. 
Acta. 1031,225-246 (1990), 
[9] B. C. Pressman, Biological applications of ionophores. Aon. Rev. Biochem. 45: 
501-529 (1976). 
[10] J. L. Sutko, H. R. Besch, J. C. Bailey, G. Zimmerman, and A. M. Watanabe, Direct 
effects of the monovalent cation ionophores monensin and nigericin on myocardium. 
J. Pharmacol. Exp. Ther. 203\ 685-700 (1977). 
[11] M. Shlafer, and P. Kane, Subcellular actions and potential adverse cardiac effects of 
the cardiotonic ionophore monensiru J. Pharmacol. Exp. Ther. 214: 561-S12> 
(1980). 
[12] K. Tsuchida, and S. Otomo, Electrophysiological effects of monensin, a sodium 
ionophore, on cardiacpurldnje fibers. Eur. J. Pharmacol.. iPO, 313-320 (1990). 
[13] J. Somberg, and B. Greenfield, Digitalis: Historical development in clinical 
medicine. J. Clin. Pharmacol. 25,484-489 (1985). 
[14] W. H. Barry, and J. H. B. Bridge, Intracellular calcium homeostasis in cardiac 
myocytes. Circulation. 87(6), 1806-1815 (1993). 
[15] D. S. Miura, and S. Biedert, Cellular mechanisms of digitalis action. J. Clin. 
Pharmacol. 25,490-500 (1985). 
[16] J. W. Deitmer, and D. Ellis, Intracellular sodium activity of cardiac purldnje fibers 
during inhibition and reactivation of the Na-K pump. J. Physiol. (Zok^/.) 284, 241-
259 (1978). 
[17] D. A. Eisner, W. J. Lederer, and R. D. Vaughan-Jones, The control of tonic tension 
by membrane potential and intracellular sodium activity in the sheep cardiac purldnje 
fibre. J. Physiol. (Io«<3?.). 335, 723-743 (1983). 
[18] C. O. Lee, and M. Dagostino, Effect of strophanthidin on intracellular Na ion activity 
and twitch tension of constantly driven canine cardiac purldnje fibers. Biophys. J. 
40, 185-198 (1982). 
[19] A. Fabiato, and F. Fabiato, Calciian release from sarcoplasmic reticulum. Circ. Res. 
40, 119-129 (1977). 
[20] D. Kim, E. J. Cn^oe, and T. W. Smith. Relations among sodium pump inhibitions, 
Na-Ca and Na-H exchange activities, and Ca-H interaction in cultured chick heart 
cells. Circ. Res. 60, 185-193 (1987). 
[21] P. A. Poole-Wilson, Regulation of intracellular pH in the myocardium; relevance to 
pathology. Mol. Cell. Biochem. 89, 151-155 (1989). 
[22] C. Orchard, The effect of acidosis on excitation-contraction coupling in isolated 
ferret heart muscle. Mol. Cell. Biochem. 89, 169-173 (1989). 
[23] E. M. Blanchard and R. J. Solaro, Inhibition of the activation and troponin calcium 
binding of dog cardiac n^ofibriles by acidic pH. Circ. Res. 55: 382-391 (1984). 
[24] K. Taubert, J. T. Willerson, W. Shapiro and G. H. Templeton, Contraction and 
resting stiffness of isolated cardiac muscle: effects of inotropic agents. Am. J. 
Physiol. 1 (3): H275-H282 (1977). 
[25] W. G. Wier and P. Hess, Excitation-contraction coupling in cardiacpurldnje fibers. 
Effects of cardiotonic steroids on the intracellular (Ca) transient, membrane 
potential, arui contraction J. Gen. Physiol. 83: 395-415 (1984) 
[26] M. M. Adamantidis, E. R. Honore and B. A. Dupuis, Electrical and mechanical 
effects of new aminosteroids on guinea-pig isolated ventricular muscle. Br. J. 
Pharmacol. 95: 1063-1074(1988). 
[27] F. H. Brian and B. Jr. Thomas, Digitalis and allied cardiac glycosides. Goodman 
and Gilman's the pharmacologic basis of therapeutics. Eighth edition. 815. 
[28] E. Honore, M. M. Adamantidis, B. A. Dupuis, C. E. Challice and P. Guilbault, 
Calcium channels  and exci tat ion-contract ion coupling in cardiac cel ls .  I I .  A 
pharmacological stiufy of the diphasic contraction in guinea-pig papillary muscles 
Can. J. Physiol. 65: 1832-1839 (1987). 
[29] E. Honore, M. M. Adamantidis, B. A. Diq)uis, C. E. Challice and P. Guilbault, 
Calcium channels and excitation-contraction conpling in cardiac cells. I. Two 
components of contraction in g i^nea-pig papillary muscles. Can. J. Physiol. 65: 
1832-1839 (1987). 
[30] G. W. Snedecor and W. G. Cochran, Statistical methods. Eight edition. 227 (1989). 
[31] J. P. Morgan, The effects of digitalis on intracellular calcium transients in 
mammalian worMngmyocardiian as detected with aequorin. J. Mol. Cell Cardiol. 
17: 1065-1075 (1985). 
[32] E. Marban and R. W. Tsien, Enhancement of calcium current during digitalis 
inotropy in mammalian heart: Positive feed-back regulation by intracellular 
Calcium? J. Physiol (Lond). 329: 589-614 (1982). 
53 
TABLE 1. Means of contraction force, initial contraction velocity, average contraction 
velocity, initial relaxation velocity and stimulus to response time of g;iinea-pig 
papillary muscles treated with digoxin (3 jimol/1), monensin (7 }imol/l) and control 
(alcohol). Data are presented as means ± SDM (n=20). CF; contraction force, ICV; 
initial contraction velocity, ACV; average contraction velocity, niV; initial relaxation 
velocity, ST; stimulus to response time. 
DRUG 
Variable Time Digoxin Monensin Control 
CF(g) 0 0.44 ±0.05 0.40 ±0.05 0.43 ±0.05 
1 0.66 ±0.05 0.64 ± 0.05 0.48 ± 0.05 
2 0.51 ± 0.05 0.64 ± 0.05 0.50 ± 0.05 
3 0.29 ± 0.05 0.62 ± 0.05 0.46 ± 0.05 
4 0.16 ±0.05 0.61 ±0.05 0.40 ± 0.05 
ICV (g/sec) 0 1.8 ±0.4 1.7 ±0.4 1.5 ±0.4 
1 3.9 ± 0.4 3.3 ± 0.4 1.8 ±0.4 
2 2.6 ± 0.4 3.1 ±0.4 2.3 ± 0.4 
3 2.1 ±0.4 3.8 ±0.4 2.3 ±0.4 
4 1.0 ± 0.4 3.8 ±0.4 1.9 ±0.4 
ACV (g/sec) 0 1.4 + 0.2 1.3 ±0.2 1.2 ±0.2 
1 2.5 ± 0.2 2.4 ±0.2 1.4 ±0.2 
2 2.2 ±0.2 2.9 ±0.2 1.7 ±0.2 
J 1.3 ± 0.2 2.8 ± 0.2 • 1.6 ±0.2 
4 0.7 ± 0.2 3.0 ± 0.2 1.4 ±0.2 
IRV (g/sec) 0 0.8 ±0.1 0.8 ±0.1 0.9 ±0.1 
1 1.6 ±0.1 1.5 ±0.1 1.2 ±0.1 
2 2.0 ±0.1 1.7 ±0.1 1.2 ±0.1 
J 1.0 ±0.1 1.8 ±0.1 1.1 ±0.1 
4 0.6 ±0.1 1.7 ±0.1 1.1 ±0.1 
ST (msec) 0 54 ± 3.8 47 ± 3.8 53 ±3.9 
1 44 ±3.8 38 ±3.8 48 ±3.9 
2 31 ±3.8 33 ±3.8 45 ± 3.9 
J 28 ±3.8 35 ±3.8 45 ± 3.9 
4 17 ±3.8 36 ±3.8 40 ±3.9 
FIG. 1. Dose response cxirve of digoxin. The largest contraction force was obtained by 
using 3 (imol/1 digoxin. Lsmean + SDM is shown (n=4). 
Contraction amplitude (mm) 
FIG. 2. Dose response curve for monensin. The largest contraction force was obtained 
by using 7 nmol/l monensin. Lsmean + SDM is shown (n=4). 
Contraction amplitude (mm) 
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FIG. 3. Plot of the CF means of guinea-pig papillary muscles in five time periods for three 
drugs (control, 3 ^mol/1 digoxin and 7 jimol/1 monensin). The drug by time 
interaction was significant, P < 0.05. * indicates that comparison of drug mean 
with the control mean is significant at P < 0.05. Lsmean + SDM is shown 
(n=20). 
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FIG. 4. Plot of the ICV means of guinea-pig papillary muscles in five time periods for 
three drugs (control, 3 pmol/l digoxin and 7 jimol/l monensin). The drug by time 
interaction was significant, P < 0.05. * indicates that comparison of drug mean 
with the control mean is significant at P < 0.05. Lsmean + SDM is shown 
(n=20). 
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FIG. 5. Plot of the ACV means of guinea-pig papillary muscles in five time periods for 
three drugs (control, 3 jimoI/1 digoxia and 7 }imol/l monensin). The drug by time 
interaction was significant, P < 0.05. * indicates that comparison of drug mean 
with the control mean is significant at P < 0.05. Lsmean + SDM is shown 
(n=20). 
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FIG. 6. Plot of the IRV means of guinea-pig papillary muscles in five time periods for 
three drugs (control, 3 junol/I digoxin and 7 funol/1 monensin). The drug by time 
interaction was significant, P < 0.05. * indicates that comparison of drug mean 
with the control mean is significant at P < 0.05. Lsmean + SDM is shown 
(n=20). 
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FIG. 7. Plot of the ST means of guinea-pig papillary muscles in five time periods for three 
drugs (control, 3 [imoL/1 digoxin and 7 jimol/l monensin). The drug by time 
interaction was significant, P < 0.05. * indicates that comparison of drug mean 
with the control mean is significant at P < 0.05. Lsmean + SDM is shown 
(n=2G). 
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FIG. 8. Representative tracing of monensin- and digoxin-induced increase in CF of 
guinea-pig papillary muscles with time. Digoxin produced after contractions 
starting at T2. 
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DIGOXIN AND MONENSIN INDUCED CHANGES OF INTRACELLULAR Ca^^ 
CONCENTRATION IN ISOLATED GUINEA-PIG VENTRICULAR MYOCYTES 
A paper to be submitted to the Journal of Action and Agent 
Ismail Merai, Frederick B. Hembrough and Walter Hsu 
Abstract 
This study was undertaken to determine the possible mechanisms of action of 
monensin and digoxin by using isolated guinea-pig ventricular myocytes. Since Ca^"^ is the 
major signal for triggering contraction of cardiac muscle, the objective of this study was to 
determine whether monensin- or digoxin-induced cardiac muscle contractions are mediated 
through an increase in Ca^^ influx. We used three different concentrations of digoxin (0.3, 
1 and 3 iamol/1) and three different concentrations of monensin (0.3,1 and 3 |4mol/l) in 
Experiment 1. Each treatment was monitored for two hours by using computerized 
fluoroscopy. Both digoxin and monensin increased the [Ca^"^]; and accelerated the onset 
time of [Ca^"^; increase in a dose-dependent manner. The largest increase in [Ca^"^; and 
2"^ 
shortest onset time of [ Ca ]; increase were obtained by using 3 jimol/l monensin and 3 
jmiol/l digoxin. In Experiment 2, we compared normal myocytes (these cells were loaded 
with fura-2 for 30 min before the treatment) to "weakened" myocytes (these cells were 
loaded with fura-2 for 3 hours before the treatment to create a "weakened" condition). We 
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found that although 0.3 |imol/l monensin and digoxin did not change the [Ca^"^]; in normal 
myocytes, they increased the [Ca^^j in "weakened" myocytes. In Experiment 3, we used a 
Na"^-free medium to demonstrate the effect of [Na'^ j, on both monensin- and digoxin-
induced increases in [Ca^^];. We found that digoxin did not increase the [Ca^"*^]; in the Na'-
free mediimi. Although monensin increased the [Ca^"^]; in the Na^ -free solution, this 
increase was not as large as in the Na'^ -containing medium. In Experiment 4, we used a 
Ca -free medium to demonstrate whether monensin- or digoxin-induced increases in 
[Ca^"^; is mediated throiigh an increase in Ca^^ influx or release. Most of the myocytes did 
not respond to caffeine control treatment after two hours of experimentation. However, 
myocytes which responded to caffeine treatment after two hours of experimentation did not 
respond to either digoxin, monensin or control treatment. We concluded that the positive 
inotropic effect of digoxin depends on [Na^]^. However, monensin increases [Ca^^; in 
Na^-dependent and -independent manners. We also concluded that "weakened" myocytes 
are more sensitive to the monensin and digoxin treatment than normal myocytes. 
Introduction 
Contraction of cardiac muscle is initiated by increased intracellular Ca^"^ 
concentration, [Ca ]•,. It has been suggested [4,12] that many positive inotropic agents, 
such as the digitalis glycosides (e. g. digoxin) and a carboxylic ionophore antibiotic, 
monensin, act by increasing [Ca^"^;. 
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Although digitalis glycosides have been used in the treatment of arrhythmias and 
congestive heart failure (CHF) for over two hundred years, the mechanism of their positive 
inotropic action remains controversial [3]. The most widely accepted mechanism is their 
well-known inhibitory effect on the Na"^, -ATPase resulting in an increase in intracellular 
Na^ concentration ([Na^;) which leads to an increase in [Ca^"^]; through the Na^ (out)/ 
(in) exchange resulting in an increased CF [1,4, 5,6, 7J. 
Monensin is a strong positive inotrope for cardiac muscle [8,9,10]. This effect 
occurs because as an ionophore monensin has a strong affinity for [Na'^ g. The affinity of 
monensin for Na^ is ten times that for IC, its nearest competitor in biological systems [11]. 
The movement of Na^ into a cellular compartment by monensin facilitates the entry of 
Ca^* into the cell by aNa^ (out) / Ca^"^ (in) exchange [12]. This Ca^^ shift is the primary 
factor mediating the cellular response. Other factors modifying cellular responses mclude 
the alteration of pH of intracellular fluid since monensin increases the pH; by transferring 
protons out of the cell [11]. 
The positive inotropic effect of digoxin depends strongly on the initial condition of 
the muscle [2]. If the capacity of heart muscle to develop CF is greatly depressed, the 
effects of <^goxin are much larger than would occur in normal muscle [2]. In a preliminary 
experiment we observed that after three hours of e^qxjsure to fura-2, the [Ca^"^; of myocytes 
gradually decreased by 20% (unpublished data). This observation gave us the idea that 
these cells could be used as "weakened" cells. 
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This experiment is the first one that compares monensin to digoxin regarding their 
effects on [Na"*"]; and [Ca^"^]; in gxiinea-pig ventricular myocytes. The present study is also 
the first one that compares monensin to digoxin without electrically stimulating ventricular 
myocytes and monitors effects of these drugs on [Na^j and [Ca^"*!; in guinea-pig ventricular 
myocytes for two hours. Mthout using an electrical stimulus, we avoided the involvement 
of stimulating the voltage-dependent Ca channels in our experiment This experiment 
was designed to examine whether: 1) the monensin- or digoxin-mediated increase in 
[Ca^"^]; is due to Na"^ entry; 2) "weakened" cells are more responsive to monensin and 
digoxin than normal cells with regard to their effects on [Ca^^];; and 3) the monensin- or 
2^ 2^ digoxin-mediated increase in [Ca ]; is due to an increase in Ca influx or release. 
Materials and Methods 
Isolation and Loading of Myocytes 
Cardiac ventricular myocytes were isolated firom the right ventricle of guinea-pig 
hearts according to a previously described method [13,14]. In brief, guinea-pigs, 400-600 
g, were heparinized (2000 lU per animal^ IP injection) thirty minutes before being 
decapitated. Hearts were removed rapidly and put in a beaker filled with ice-cold non­
standard BCrebs-Ringer bicarbonate solution (KRB) of the following composition [mmol/1]: 
Na^ 116; Ca^^ 2.2; K^, 4.0; Mg^^ 1.3; Cr, 126.9; H2P04-, 2.1; HCO3', 21.7; glucose, 10.9 
and HEPES, 10. The pH was adjusted to 7.4 at room temperature. The hearts were then 
rapidly put in a glass pan filled witii KRB and perfused with 100 % O2 at room 
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temperature. The aorta was rapidly cannulated to perfuse the coronary arteries on a 
modified Langendorff apparatus (Fig. 1). The heart was first perfused with BCRB at 34 °C 
for about 5 min. at a hydrostatic pressure of 90 cm of H2O, then with a Ca^^-free Tyrodes 
solution of the following composition [mmol/1]: Na^, 116; Ca^"^, 0; K^, 4.0; Mg^"^, 1.3; CI", 
126.9; H2PO4', 2.1; HCO3*, 21.7; glucose, 10.9; HEPES, 10 (pH was adjusted to 7.3 at 37 
°C) for 5 min., and finally with 10 mg collagenase (Worthington Biochem. Co., Freehold, 
New Jersey) and 1.7 mg protease (Sigma Chemical Co., St. Louis, MO) in 25 ml of Ca^"^-
free Tyrodes solution which was recirculated using a pump for 10-15 min. The heart was 
washed with a high solution (storage solution) of the following composition [mmol/1]: 
KOH, 70; L-glucuronic acid, 50; KCl, 40; taurine, 20; KH2PO4,20; MgCl2,3; glucose, 10; 
HEPES, 10; EGTA, 0.5; pH was adjusted to 7.3 at 37 °C and ventricles were minced and 
poured into a beaker. The myocytes were dispersed by gently shaking the beaker. The 
myocytes were centrifuged at 1000 X g for 2 min and washed with KRB. The dispersed 
myocytes were allowed to attach to dishes at room temperature for 15 min Some of the 
cells were stored in a storage solution at 4 °C for use on the second day. The attached 
myocytes were washed with KRB and loaded with 3 |jinol/l fura-2 acetoxymethylester 
(Molecular Probes, Eugene, OR) for 30 min at 37 "C, aerated witii 5% CO2 and 95% air. 
Then, the loaded myocytes were rinsed with KRB. Two ml of KRB was added to each 
dish. The fura-2 fluorescence was monitored by using a computerized fluoroscope 
(Attofluor™ Ratio Vision™ Version 6.00, Atto Instruments, Torrance, CA.). 
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Experiment 1. Dose response curve for digoxin and monensin 
Seven treatments were used; control (0.18% alcohol), monensin (0.3,1 and 3 
^mol/1) and digoxin (0.3,1 and 3 (imol/l). Each treatment was monitored for two hours 
and replicated three times. Twenty mmol/1 KCl was added two hours after each experiment 
to test whether the cells would respond to this control treatment by increasing influx 
through VDCCs. 
Experiment 2. Differences between "weakened" and normal myocytes 
This experiment tested whether there were differences between "weakened" 
myocytes and normal myocytes in the action of monensin and digoxin. Myocytes were 
loaded with fura-2 three hours before treatment (this caused a gradual decrease in [Ca^"^]; 
producing a "weakened" cell). Three treatments were used: control, monensin (0.3 |imol/l) 
and digoxin (0.3 pnaol/1). Twenty mmol/1 KCl was added two hours after the control 
treatment to test whether the cells would respond to this control treatment. 
Experiment 3. Effects of monensin and digoxin on [Ca^^Ji of cardiac lipocytes in Na -^free 
medium 
To investigate whether an increase in induced by monensin or digoxin is due 
to Na"*" influx, a Na"^-free medium was used. The cell preparation and loading were the 
same as in Experiment 1. The loaded cells were washed with KRB. Two ml of Na^-free 
medium of following composition [imnol/1]; choline chloride, 116; MgCl2,1.3; K2HPO4,2; 
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glucose, 10.9; CaCl2,2.2; HEPES, 10 (pH was adjusted to 7.4 at room temperature) was 
added to each dish and fura-2 fluorescence was monitored. In this experiment we replaced 
NaCl with CHCl (LiCl was also used to replace NaCl but it caused simultaneous 
contraction of myocytes). Twenty mmol/1 KCl was added two hours after each experiment 
to test whether cells would respond to this control treatment. Three treatments were used: 
control, monensin (3 nmol/1) and digoxin (3 |imol/l). 
Experiment 4. Effects of monensin and digoxin on [Ca^*]i of cardiac myocytes in -free 
medium 
To investigate whether an increase in [Ca^^]; induced by monensin or digoxin is 
due to Ca^"^ influx or a Ca^"^ release from the SR, a Ca '^^ -free medium of the following 
composition [namol/l]: Na^, 116; EGTA, 0.01; 4.0; Mg^"^, 1.3; CT, 126.9; H2PO4', 2.1; 
HCO3*, 21.7; glucose, 10.9; HEPES, 10 (pH was adjusted to 7.4 at room temperature) was 
used. The cell preparation and loading were the same as in Experiment 1. Two ml of Ca^"^-
free medium was added to each dish and ftira-2 fluorescence was monitored. Three 
treatments were used; control, digoxin (3 iamol/1) and monensin (3 pmol/1). Ten mmol/1 
cafifeine was added two hours after each experiment to test whether these cells would 
respond to this control treatment by increasing release from intracellular stores.. 
Data expression and Analysis 
[Ca^"^]; is expressed by the ratio of the emission of fura-2 at 340 to that at 380 nm. 
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There are two different forms of fura-2: Ca '^*'-binding form that is excited at 340 mn and 
Ca '^*'-free that is excited at 380 nm. If there is an increase in [Ca^"^];, this would increase the 
340/380 ratio by increasing the emission at 340 nm and decreasing the emission at 380 nm. 
Onset time of is expressed as the starting time of the increase in 340/380 ratio. The 
data were expressed as mean ± standard deviation (SD) and analyzed using analysis of 
variance (ANOVA). Tukey's test was used to test for differences among means for which 
ANOVA indicated a significant {P < 0.05) F ratio [see appendix for ANOVA tables]. 
Results 
Experiment 1. Dose response curve for digoxin and monensin 
The effect of three different concentrations of digoxin on [Ca^"^! of guinea-pig 
ventricular myocytes is shown in Fig. 2. Digoxin increased the [Ca^^; and decreased the 
onset time of [Ca^^]i increase in a dose-dependent maimer (Table 1). 0.3 nmol/1 digoxin 
did not change the [Ca^"*"]; in the two hours of the experimental period. One jimol/1 digoxin 
increased the [Ca^^; (from 0.60 ± 0.03 to 1.04 ± 0.39) 75 ± 5.47 min after treatment. 
However, a significant increase in [Ca^^]; (from 0.60 ± 0.03 to 1.85 ± 0.13) occurred 
earlier (58 ± 3.2 min) when using 3 jamol/1 digoxin. 
The effect of three different concentrations of monensin on [Ca^"^]; of gunaea-pig 
ventricular myocytes is shown in Fig. 3. Monensin also increased the [Ca^"*"]! and 
decreased the onset time of [Ca^"^-, increase in a dose-dependent manner (Table 1). 0.3 
(imol/1 monensin did not change the [Ca^"^; in two hours of exposure. One (imol/1 
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monensin increased the [Ca^"^]! (from 0.60 ± 0.03 to 1.13 ± 0.49) 80 ± 4.2 min after 
treatment However, a significant increase in [Ca^^; (from 0.60 ± 0.03 to 2.80 ± 0.90) and 
shorter onset time (62 ± 4.2 min) were obtained by using 3 [imol/l monensin (Fig. 3). 
[Ca^"^! gradually decreased by 15% over the two-hour period in the control myocytes. 
However, these cells responded to 20 mmol/1 KCl treatment by increasing [Ca^^]-, (from 
0.58 ± 0.03 to 1.20 ± 0.69) at the end of the experiment 
Representative tracing of monensin- and digoxin-induced increase in [Ca^"^]; and 
onset time for this increase is shown in Fig. 6. Both monensin and digoxin increased the 
[Ca^"^; of guinea-pig ventricular myocytes. 
Experiment 2. Differences between "weakened" and normal myocytes 
Although both digoxin (0.3 jimol/1) and monensin (0.3 nmol/1) did not change the 
[Ca^^i of normal guinea-pig ventricular myocytes (Fig. 4), both of these drugs (0.3 |amol/l) 
mcreased the [Ca^"^]; of "weakened" guinea-pig ventricular myocytes (Fig. 4). An increase 
in (from 0.63 ± 0.03 to 2.76 ± 0.87) by digoxin occurred 93 ± 4.5 min after 
treatment and it (from 0.63 ± 0.03 to 2.81 ± 0.16) occurred 92 ± 5.4 min after treatment 
when using monensin. In control myocytes, [Ca^^-, gradually decreased by 15% over a 
two-hour period (Table 1). However, these cells responded to a treatment with 20 nmiol/1 
KCl by increasing [Ca^^i (from 0.60 ± 0.03 to 0.94 ± 0.04) at the end of the experiment 
79 
Experiment 3. Effects of monertsin and digoxin on [Ca^*]i of cardiac myocytes in Na*-free 
meditan 
Although 3 |imol/l digoxin increased the [Ca^"^]; of myocytes in a Na'^ -containing 
medium (Fig. 2), it did not increase the [Ca^"^; of myocytes in a Na'^ -free medium during 
the two hours of treatment (Fig. 5). However, application of KCl (20 mmol/1) after digoxin 
experiment, increased [Ca^"^! (from 0.55 ± 0.04 to 0.97 ± 0.06) of myocytes in a Na'^ -free 
medium. Monensin, on the other hand, increased the [Ca^"^]; (from 0.70 ± 0.08 to 2.06 ± 
1.07) of myocytes in a Na"^-free medium 68 ± 5.6 min after treatment (Fig. 5). However, 
the increases in [Ca^"^! by monensin in a Na^-free medium was less than that in a Na^-
containing medium. In control myocytes, [Ca^"^; gradually decreased by 15% over a two-
hour period (Table 1). However, these cells responded to the treatment with 20 mmol/1 
KCl by increasing [Ca^^j (from 0.60 ± 0.03 to 1.06 ± 0.21) at the end of the experiment. 
Discussion 
This study is the first one to show that digoxin and monensin increase the [Ca""^]; in 
guinea-pig ventricular myocytes. Both digoxin and monensin increased the [Ca^"^]; and 
decreased the onset time of [Ca^"^; increase in a dose-dependent manner. The positive 
inotropic action of digoxin is caused by the inhibition of Na^, K^-ATPase. As a result, 
there is a gradual increase in [Na"^]; and a gradual small decrease in [K^Jj [15,16]. It is the 
increase in jNa^j that can be judged to be crucially related to the positive inotropic effect 
of digoxin. An increase in [Na^j by digoxin raises the [Ca^"^; due to the entry of Ca^"^ 
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into the cell by Na^ (out) / Ca^"^ (in) exchange [17], It has been shown that the Na^-Ef*" 
exchange also appears to play a role in amplifying the increase in [Ca^"^]; that results from 
inhibition of the Na"^, K'^ -ATPase. The increase in [Na"^; causes a fall in pH;, as [H^]o are 
exchanged for intracellular Na^ to lower the increased [Na*]; [18]. In experiment 1, we 
were able to demonstrate that 3 jimol/l digoxin increased [Ca^^; of myocytes two hours 
after treatment. However, the increase in [Ca^^]-, by digoxin was gradual. It took about 70 
min for digoxin to reach plateau. This result suggested that it takes time for digoxin to 
inhibit Na^ K"^- ATPase and increase [Ca^^]i by increasing [Na*];. Further studies 
measuring changes in [Na^Jj would be needed to confirm our hypothesis. This resxilt is 
consistent with the results of our papillary muscle contraction experiment showing that 
digoxin caused a significant increase in contraction force of guinea-pig papillary muscles 
60 min after treatment (see chapter 1). 
Monensin has been characterized as a Na^ ionophore by virtue of its ability to form 
a lipid-soluble cation complex that can rapidly traverse cell membranes. Monensin binds 
Na"^ outside of the myocytes and carries it into the cell and increases [Na"^]; and thus [Ca^"^]; 
[11]. Monensin also increases the pH; due to the transferring of protons to outside the cell 
[11]. Contraction of the heart is pH sensitive; classically an alkalosis increases [Ca^^]; by 
stimulating the Na^ / exchange [19,20]. An increased pHj by monensin may also 
increase [Ca^"^; by stimulating the Na^ / Ca^"^ exchange. In this experiment we were able to 
demonstrate that 3 jjmol/1 monensin increased [Ca ]; in normal myocytes. The increase in 
[Ca^"^; by monensin was also gradual. It took about 70 min for monensin to reach a 
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plateau. This result suggests that it takes time for monensin to increase [Ca^"^]; of myocytes 
by increasing [Na^];. Further studies measuring changes in [Na^; and pHj would be needed 
to confirm our hypothesis. This result is consistent with the results of our papillary muscle 
contraction experiment (unpublished data) showing that monensin caused a significant 
increase in contraction force of guinea-pig papillary muscles 60 min after treatment 
"Weakened" cells were different from normal cells because of the decreased basal 
[Ca^"^];. There may be two reason for the decreased [Ca^"^]; of "weakened" cells. Although 
both digoxin (0.3 |jjnol/l) and monensin (0.3 tmaol/l) did not change the [Ca^^]; of normal 
guinea-pig ventricular myocytes, both of these drugs (0.3 ^mol/1) increased the [Ca^^jj of 
"weakened" guinea-pig ventricular myocytes (Fig. 4). This result is consistent with the 
following concept: When the capacity of heart muscle to develop force is greatly 
depressed (such as due to the decreased [Ca ];), the effect of these two drugs is much 
greater than would occur in normal muscle [2]. 
Although 3 jimol/l digoxin increased the [Ca^^; of myocytes in Na^-containing 
medium two hours after the treatment, it did not increase [Ca^^]i of myocytes in Na"^-free 
medium two hours after the treatment (Fig. 5). However, KCl (20 mmol/1) addition, after 
digoxin exposure, still increased [Ca ]; of myocytes in a Na -free medium indicating that 
voltage dependent Ca '^^ -channels (VDCCs) fimction normally in these cells. This result 
clearly indicated that digoxin needs [Na^,, to increase [Ca^"^!. This result also clearly 
demonstrated that digoxin does not directly effect either the release of from the SR or 
influx of the Ca^"^ through VDCCs in the absence of extracellular Na^. Our result is 
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consistent with the concept that it is the increase in [Na^]; that is related to the positive 
inotropic efifect of digoxin. An increase in [Na"^]; by digoxin increases the [Ca^"^]; due to 
the entry of Ca^"^ into the cell by Na^ (out) / Ca^"*" (in) exchange [4,5,6,7]. Monensin, on 
the other hand, increased [Ca^"^]} of myocytes in both the Na^-containing and the Na^-free 
medium two hours after treatment However, the increase in [Ca^"*"]; by monensin in a Na"^-
free medium was not as large as the increase in a Na^-containing solution (Fig. 5). The 
movement of Na^ into the cellular compartment by monensin facilitates the entry of Ca^"^ 
by a Na^ (out)/ Ca^"^ (in) exchange [12]. However, our result indicated that this increase in 
[Ca^"*"]; by monensin in Na^-free medium may be due to three reasons. First, monensin may 
be a Ca^"^ ionophore as well as a Na"^ ionophore (the ion specificity of monensin is Ag > Na 
> K > Rb > Cs > Li > Ca [11] with approximately a 10-fold selectivity for Na^ over K"^. 
Second, monensin may open the VDCCs of guinea-pig myocytes by increasing [K"^]; in 
Na"^-free medium. In the absence of [Na"^],,, monensin might work as a ionophore and 
increase the [K^j and thus, opening of VDCCs. Further studies by measimng [K"^]; are 
needed to demonstrate that in a Na"^-free medium, monensin increases the [K^]; by acting as 
aK"^ ionophore. By using a Na"*"-containing medium Hugtenburg. et. al. [21] suggested that 
the positive inotropic effect of monensin in guinea-pig papillary muscles is nearly 
insensitive to inhibition by nifedipine (an L-type Ca^"*" channel blocker) and is only partially 
blocked by ryanodme (a ryanodine channel blocker). He also si^gested that the partial 
inhibitory effect of ryanodine suggests that a part of the monensin-induced [Ca^^; is taken 
up by the SR. This findings and our findings support the hypothesis of Fabiato [22] that 
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Ca^"*" introduced into the cell by the Na^/ Ca^"^ exchange, in addition to the influx through 
VDCCs, might also contribute to the reloading of the SR. However, there may be an influx 
of Ca^"^ through channels other than VDCCs [23]. 
Because the effects of monensin (3 fxmol/l) and digoxin (3 fimol/1) to increase 
[Ca^"^]! in guinea-pig ventricular myocytes took a long time (aroimd 60 min), our Ca^"^ -free 
experiment did not give us consistent results as most of the myocytes did not respond to the 
caffeine (10 mM) treatment after the two hours of experimental period due to the depletion 
of SR. However, we observed that the cells which responded to caffeine treatment after 
two hours of experimentation did not respond to either digoxin, control or monensin 
treatment Further studies are needed to confirm the idea that these drugs do not affect the 
SR to release Ca inCa -free medium. It has been shown that ouabain, another cardiac 
glycoside, used at a higher concentration (1 mmol/l) did not increase the [Ca^"^! of rat 
ventricular myocytes in the Ca^"^ -free medium [24]. 
We also attempted to use thapsigargin (200 nmol/1) which is a SR Ca^"^ ATPase 
blocker [25] to deplete the SR. However, thapsigargin did not deplete the SR without 
electrical stimulation. Since we did the experiments without stimulating the cells, it was 
not proper for us to compare the stimulated myocytes to un-stimulated myocytes with 
regard to [Ca ]; changes. Thapsigargin experiments need to be performed with electrically 
stimulated guinea-pig ventricular myocytes. 
We concluded that, it is the increase in [Na'*^i that is crucially related to the positive 
inotropic effect of digoxin. An increase in [Na ]; by digoxin increases the [Ca ]i due to 
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the entry of Ca^"^ into the cell by Na^ (out) / Ca^"^ (in) exchange. Although [Na^]i is 
important for the inotropic action of monensin, this agent may also increase [Ca^^Jj due to 
either carrying inside the cell, opening VDCC or releasing Ca^"^ from the SR. 
Because both monensin and digoxin change the pHj and increase the [Ca^"^]; by 
increasmg [Na"^]; of myocytes, fijrther studies are needed: 1) for monitoring pH;, [Na^; and 
[Ca^^i; and 2) for comparing unstimulated myocytes vs stimulated myocytes to evaluate 
whether [Ca^"^; and onset time of increased [Ca^^j of stimulated myocytes, induced by 
monensin and digoxin, are different. 
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Table 1. Means of ratio and onset time of [Ca^"^]; increase of ventricxilar myocytes treated 
with monensin and digoxin. Data are presented as mean ± standard deviation (SD). 
TRT CELL TYPE ONSET RATIO 
TIME (Min) (340/380) 
Experiment 1 
Control Normal — 0.60 ±0.03 
Digoxin 0.3 fimol/1 Normal — 0.70 ± 0.06 
Digoxin 1 ^ol/l Normal 75 ± 5.4 1.04 ±0.39 
Digoxin 3 nmol/1 Normal 58 ±3.2 L85±0.13 
Monensin 0.3 nmol/l Normal — 0.71 ±0.03 
Monensin 1 nmol/1 Normal 80 ±4.2 1.13 ±0.49 
Monensin 3 jimol/1 Normal 62 ±4.2 2.80 ±0.90 
Experiment 2 
Control "weakened" — 0.63 ± 0.03 
Digoxin 0.3 jimol/1 "weakened" 93 ±4.5 2.76 ±0.87 
Monensin 0.3 pmoI/1 "weakened" 92 ± 5.4 2.76 ±0.16 
Experiment 3 
Control Na'^ -fiee — 0.70 ± 0.08 
Digoxin 3 nmol/1 Na"*"-free — 0.55 ± 0.04 
Monensin 3 [jimol/l Na '^-free 68 ± 5.6 2.06 ±1.07 
Fig. 1. Schematic illustration of a modified Langendorff apparatus. 
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FIG. 2. Dose response of digoxin. The largest increase in [Ca^^; was obtained by 
using 3 pmol/1 digoxin. Means + SD is shown (n=3). * denotes a 
significant difference between control and treatment mean, P < 0.0001. 
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FIG. 3. Dose response of monensin. The largest increase in [Ca^^j was obtained by 
using 3 jimol/l monensin. Means + SD is shown (n=3). * denotes a 
significant difference between control and treatment mean, P < 0.0001. 
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FIG. 4. Effects of monensin (0.3 jimol/1) and digoxin (0.3 pnol/l) in [Ca^^j of 
"weakened" cells. Means + SD is shown (n=3). * denotes a significant 
difference between control and treatment mean, P < 0.0031. 
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FIG. 5. Effects of monensin (3 |amol/l) and digoxin (3 }imol/l) on of cardiac 
myocytes in Na'*'-free medium. Means + SD is shown (n=3). * denotes a 
significant difference between control and treatment mean, P < 0.016. 
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FIG. 6. Representative tracing of monensin- and digoxin-induced increase in of 
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GENERAL DISCUSSION 
Contraction velocity is used as an indicator of how well cardiac tissue functions. It 
can be used to assess the function of the sarcomere, the myocyte, a papillary muscle, 
ventricular strips, or an intact heart. 
The inverse relationship between load and velocity of contraction was one of the 
first to be established in cardiac mechanics. This is usually associated with afterload. 
When the load is zero the derived from an afterload curve, with a constant preload, is 
a theoretical value which is considered to be a Tnavimnm velocity with a given state of 
contractility. However, with an increasing preload (on the ascending limb of a preload 
curve) the velocity is directly related to the preload (or to the length of muscle), if the 
afterload is constant theoretically, V^ax does not change. The unloaded (afterload) velocity 
of cardiac muscle contraction is strongly [Ca ]; dependent This is not true of skeletal 
muscle (Sauders, 1989). 
If an adult (intact) heart is considered, the velocity of contraction is a variable that 
gives important information in regard to fvmction. Of the many examples available, cardiac 
enlargement serves well to demonstrate the value of the velocity term. Some authors 
classify cardiac enlargement as "hypertrophy" and "dilatation". Hypertrophy is then 
subdivided into two parts as: "concentric hypertrophy" (caused by a pressTire overload) and 
"eccentric hypertrophy" (caused by a volume overload). With eccentric hypertrophy the 
wall thickness may increase just enough to compensate for the increased volume (increased 
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diameter) of the chamber. In this case the velocity term can fall into the normal range of 
fimction. Whereas, with a concentric hypertrophy there is a large increase in wall 
thickness. If the increase in wall thickness equals the increase in the afterload or exceeds it, 
then the velocity term again falls within the normal range. With a true dilatation, force and 
velocity are decreased at every point along the entire ascending limb of the preload curve. 
Time is the enemy of a contracting heart. One of the better correlates with oxygen 
consumption is the time-tension index. When the velocity of contraction is low, the heart 
must contract longer (and over a longer period of the normal systolic phase because it no 
longer fimctions as an impulse producer giving momentum to the blood). This requires 
more oxygen, more energy consumption and in a sense this becomes an added afterload on 
the heart. 
The velocity of contraction is directly related to the crossbridge cycling rate and this 
is directly related to the myosin-ATPase (a weak ATPase) and to the more important acto-
myosin ATPase (a strong ATPase). Therefore: anything that influences the enzyme 
systems of cardiac muscle will also influence the velocity of contraction. 
In the first study, we evaluated the efifects of monensin and digoxin on contractility 
changes in fatigued and non-fatigued guinea-pig papillary muscles. We found that both 
monensin (7 ^imol/1) and digoxin (3 jimol/l) caused a positive inotropic effect in guinea-pig 
papillary muscles. However, the positive inotropic effect of monensin lasted longer than 
ihe positive inotropic effect of digoxin. This was also true for the effect of monensin on the 
contraction velocity, as compared to both the control and the digoxin treated papillary 
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muscles. These findings are very important; as a decreased contraction velocity acts as an 
increased afterload to a fimctional heart and is an important consideration in congestive 
heart failure (CHF). 
In cardiac myocytes, a small quantity of crosses the sarcolemma and induces a 
much larger release of Ca^"^ from the sarcoplasmic reticulum (SR). The Ca^"^ that is 
released from the SR initiates contraction by binding to the contractile proteins (Barry and 
Bridge, 1993). The cross bridges that project from the thick (myosin) filaments and 
interact with the tbin (actin) filaments constitute the molecular motors that generate force in 
cardiac muscle (Fuchs, 1995). There are two routes of thin filament activation. The first 
route is based on the binding of Ca to the troponin C subunit of the regulatory complex. 
The second route is the cross bridges themselves (Fuchs, 1995). Under conditions that 
favor a strong actin-myosin binding affinity (low Mg -ATPase concentrations, low ionic 
strength), contraction can occur in the virtual absence of (Fuchs, 1995). The affinity 
Tri 
of troponin C for Ca is affected by several factors. Low intracellular pH (pHj) decreases 
the afSnity of troponin C for Ca^"^ (Blanchard and Solaro, 1984). cAMP-dependent protein 
kinase-induced phosphorylation of troponin I also decreases Ca sensitivity of troponin C 
(McClellan and Winegrad, 1980). Thus, not only the rate of increased [Ca^"^]; but also the 
afSnity of the contractile elements for Ca^^ regulates the force developed by a myocyte. 
The positive inotropic action of digoxin is due to the inhibition of Na"*", K^-ATPase. 
As a result, there is a gradual increase in (Na^i and a gradual small decrease in [K^]; 
(Deitmer and Ellis, 1978). It is the increase in [Na^j that is related to the positive 
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inotropic effect of digoxin. An increase in [Na^]; by digoxin woxild raise the [Ca"^; due to 
the pumping out this increased intracellular Na^ for the exchange of extracellular Ca^~ by a 
Na" (out) / (in) exchanger (Lee and Dagostino, 1982). Increased [Ca^"^]; causes the 
release of additional Ca^^ from the SR (Fabiato, 1983). The increase in [Na"]; is adjusted 
by a Na'^ -H"*" exchanger that pumps a Na'*' outside and a inside the myocyte. This causes 
a decrease in pH; (Kim et al., 1987). In our first study, we were able to demonstrate that 3 
Hmol/1 digoxin caused a positive inotropic action. To be able to demonstrate whether the 
digoxin-induced positive inotropic action was due to an increase in [Ca^"^]!, we measured 
[Ca^^i of digoxin (3 ^mol/1) treated guinea-pig ventricular myocytes by loading them with 
fura-2. 'We found that digoxin significantly increased the [Ca '^*']; of myocytes. 'We 
concluded that the positive inotropic action of digoxin is due to an increase in [Ca^"^];. 
However, digoxin lost its positive motropic action and caused a negative rather than a 
positive inotropic effect with the elapse of time. This may be due to several reasons. First, 
a toxic effect of digoxin occurred followed by a positive inotropic effect due to an 
excessive amount of [Ca^^];. Second, an assumed decreased pH; decreases the affinity of 
troponin C for Ca^"^. To be able to demonstrate whether digoxin-induced increases in the 
force of contraction and increases in [Ca^"^]; were due to [Na'^ jo, we used aNa"^ -free 
solution and measured the [Ca^^]i of myocytes. We found that digoxin did not increase the 
[Ca^"^]; in a Na"^ free solution. 'We concluded that the digoxin-induced increase in the force 
of contraction and [Ca^"^]; was directly related to the [Na^],,. 
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Monensin binds Na^ outside of the cell and carries it into the cell and increases 
[Na"^]i and thus [Ca^"^]; (Mollenhauer et al., 1990). Monensin also increases the pH; due to 
the transfer of a ion outside the cell (Mollenhauer et al., 1990). The 7 |imol/l monensin 
also caused a positive inotropic effect in guinea-pig papillary muscles. To be able to 
demonstrate whether monensin's induced positive inotropic action was due to an increase 
in [Ca^li, we measured [Ca^"^]! of monensin (3 nmol/1) treated guinea-pig ventricular 
myocytes by loading them with fura-2. We found that monensin significantly increased the 
[Ca^"^]; of myocytes and concluded that the positive inotropic action of monensin is due to 
an increase in [Ca^"*"]-,. Unlike digoxin, monensin did not lose its positive inotropic effect 
on guinea-pig papillary muscles with the elapse of time. This demonstrated that the 
positive inotropic effect that was obtained with monensin treatment lasted longer than 
digoxin. Elevated pHj which increases the affinity of troponin C for may partially be 
responsible for the long lasting positive inotropic action of monensin. To be able to 
demonstrate whether the monensin-induced increase in force of contraction and [Ca^"^]; is 
due to the [Na^]o, we used a Na^ -free medium and measured [Ca^"*"]; of myocytes. We 
found that monensin increased the [Ca^"^]; in Na^-free medium. We concluded that 
monensin can increase [Ca^"^]; in both the presence of [Na^J^ and in the absence of [Na^]o, 
which increases the force of contraction. 
There are two components, the early and late components, of the guinea-pig 
papillary muscle contraction wave (Vierling, 1988). The early component is suggested to 
be generated by Ca^"^ released from the SR whereas the late component is thought to result 
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from Ca^"^ flowing into the cell via the inward current (Adamantidis et al., 1988). The 
ICV would be affected by the change in the early component and the ACV would be 
affected by those factors that produce both the early and late components of the contraction 
wave (Adamantidis et al., 1988). Velocity is not affected by increased [Ca^"^]; alone. An 
increase in heart rate or temperature increases the velocity of the contraction by increasmg 
ATPase activity of myosin without changing [Ca^^j or contraction force of the 
myocardium. Both digoxin and monensin increased the velocity of contraction of guinea-
pig papillary muscles suggesting that they have a significant effect on the rate of Ca^"*" 
release from the SR, the affinity of troponin C for or myosin ATPase activity. 
Digoxin lost its effect with the elapse of time probably due to decreased pH; which 
decreases the affinity of troponin C for Ca^"^. Further studies are needed to measure pH; 
when using monensin and digoxin to confirm our hypothesis. 
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APPENDIX 
TABLE 1. Original data of manuscript one. M; muscle, ACV; average contraction 
velocity, ICV; initial contraction velocity, IRV; initial relaxation velocity, CF; contraction 
force, ST; stimulus to response time, NF; non-fatigued papillary muscles, F; fatigued 
papillary muscles. ' ' " 
ACV ICV IRV CF ST 
M Drug Method Time (mg/sec) (mg/sec) (mg/sec) (mg) (Msec) 
1  D 0  578 .S2  620 .52  301 .22  300  70 .2 'Q  
1  D NF '  .  1  1157 .27  1363 .20  642 .65  475  54 .01 '  
1  D NF 2  1793 .80  2142 .25  1577 .07  625  43 .55  
1  D NF 3  1683 .33  2320 .80  1111 .55  400  43  . 20  
1  D NF 4  1403 .15  - 1766 .62  1289 .25  275  43  . 55  
2  M NF 0  737 .22  992 .97  472 .57  225  43  . 67  
2  M NF 1  2650 .07  3279 .12  1679 .20  687 .  5  21 .61  
2  M NF 2  3783 .77  3836 .02  2585 .97  825  32 .70  
2  M NF 3  5016 .3 -7  10937 .15  2483 .22  875  10 .90  
2  M NF 4  6115 .20  10937 .15  3251 .32  1000  16 .35  
3  C  NF 0  771 .52  1002 .24  485 .54  400  64 .80  
3  C  NF 1  861 .02  1230 .98  626 .42  450  65 .32  
3  C  NF 2  1267 .50  1680 .50  796 .43  575  64 .80  
3  C  NF 3  1249 .10  1729 .38  620 .52  512  .  5  64 .80  
3  C  NF 4  1424 .35  1729 .38  689 .60  400  59 .40  
4  M F  0  1624 .35  2299 .37  1125 .16  425  32 .70  
4  M F  X 2402 .04  3251 .34  1350 .60  . 550  21 .80  
4  M 2  2637 .18  3619 .66  1455 .40  575  21 .80  
4  M p  3  3224 .81  4079 .23  1454 .43  562 .  5  21 .80  
4  M p  4  2436 .52  3425 .90  1287 .65  425  21 .80  
5  M F  0  1012 .97  1203 .45  835 .19  375  48  . 99  
5  M F  1  1589 .58  1937 .84  994 .22  450  32 .66  
5  M F  2  1457 .11  1667 .06  955 .32  412 .  5  32 .66  
5  M F  3  1501 .27  2486 .33  1014 .57  425  38  . 10  
5  M F  4  1504 .47  2017 .97  926 .02  325  43  . 20  
6  D  F  0  3654 .78  4354 .63  2139 .58  637 .5  43  . 60  
6 D F  1  1638 .00  2387 .96  1418 .96  250  32  . 70  
6 D p  2  0  0  0  0  0  
6 D F  3  0  0  0  0  0  
6 D 4  0  0  0  0  0  
7 M NF 0  717 .32  1126 .57  564 .08  250  65 .33  
7  M NF 1  1518 .94  . 2506 .38  1186 .39  525  43  . 20  
7  M NF 2  2218 .14  3281 .65  1589 .81  575  43  . 20  
7  M NF 3  2296 .06  3097 .11  2001 .83  500  43  . 55  
7  M NF 4  2367 .81  2821 .30  1320 .14  412 .5  43  . 55  
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TABLE 1. Contmued. 
8  M p  0  2770  . 95  3423  . 90  1013  . 30  725  43  .  6  0  
S  M F  X 3179  . 20  4079  . 23  1575  . 12  762 .5  43  . 60  
3  M F  2  3439  . 80  2949  . 36  1999  . 33  750  43  . 60  
8  M p  3  3898  .  44  3619  . 66  2216  . 78  850  43  . 60  
8  M p  4  4231  . 42  3802  . 24  1372  . 23  837 .5  43  . 98  
9  C  F  0  819  . 74  1002  . 24  496  . 21  425  75  . 60  
9  C  1  1132  . 13  1299  . 65  727  . 45  562 .5  70  . 20  
9  C  F  2  1918  . 66  2086  . 52  1240  . 90  787 .5  70  . 20  
9  C  F  3  1864  . 52  2320  . 82  1363  . 20  725  54  . 00  
9  C  p  4  1339  . 37  1877  . 52  832  . 20  437 .5  59  . 88  
10  C  NF 0  1519  . 24  1664  . 98  760  . 79  662  . 5  54  . 51  
10  C  NF 1  1815  . 45  2139  . 58  1101  . 29  712 .5  54  . 51  
10  C  NF 2  1629  . 41  1859  . 15  842  . 68  537 .5  43  . 98  
10  C  NF 3  1587  . 60  1875  . 17  683  . 23  450  43  . 61  
10  C  NF 4  1136  . 80  1650  . 75  520  . 84  325  49  . 48  
11  D F  0  746  . 22  918  . 62  401  . 93  325  70  . 77  
11  D F  1  2831  . 81  2700  . 53  1820  . 54  925  48  . 99  
11  D F  2  3840  . 10  3457  . 84  6009  . 45  912 .5  40  . 50  
11  D F  3  3278  . 99  4712  -68  3281  . 65  637 .5  43  . 20  
11  D F  4  . 1148  . 03  1667  . 06  1495  . 36  225  43  . 55  
12  M NF 0  1051  . 05  1575  . 12  695  . 46  412 .5  65  . 41  
12  M NF 1  4371  . 41  3251  . 34  3251  . 34  762 .5  59  . 96  
12  M NF 2  4299  . 75  4354  . 63  3251  . 34  750  32  . 70  
12  M NF 3  3663  . 02  4629  . 23  4988  . 77  725  32  . 98  
12  M NF 4  4586  . 40  3619  . 66  3093  . 24  600  32  . 70  
13  C  F  0  1983  . 13  2339  . 38  1443  . 65  637 .5  64  . 29  
13  C  F  T_ 1929  . 29  2526  . 44  970  . 73  537 .5  53  . 57  
13  C  F  2  2136  . 53  2844  . 13  908  . 29  600  48  . 60  
13  C  F  3  2296  . 06  3255  . 40  1079  . 56  700  48  . 99  
13  C  F  4  2296  . 06  3430  . 18  974  . 48  700  48  . 99  
14  M NF 0  1289  . 92  2139  . 58  625  . 65  337 .5  49  . 05  
14  M NF 1  2197  . 65  2949  . 37  1149  . 86  575  49  . 06  
14  M NF 2  2136  . 84  2697  . 16  1384  . 07  512 .5  43  . 60  
14  M NF 3  1385  . 47  2483  . 23  1229  . 44  362 .5  43  . 60  
14  M NF 4  1278  . 90  2067  . 25  1101  . 29  362 .5  65  . 41  
15  C  NF 0  771  . 52  1022  . 75  826  . 39  400  75  . 60  
15  C NF 1  956  . 02  1135  . 65  1213  . 15  475  70  . 20  
15  C NF 2  1041  . 56  1507  . 42  926  . 02  450  64  . 80  
15  C  NF 3  1035  . 47  1432  . 19  714  . 56  425  70  . 20  
15  C  NF 4  1092  . 99  1363  . 20  665  . 65  425  59  . 40  
16  D p  0  1989  . 40  2674  . 11  1004  . 64  437 .5  43  . 98  
16  D p  1  1082  . 50  1618  . 94  683  . 23  212 .5  43  . 98  
15  D p  2  0  0  0  0  0  
16  D F  3  0  0  0  0  0  
16  D  p  4  0  0  0  0  .  0  
17  C  p  0  1243  . 70  1457  . 22  574  . 01  487 .5  76  . 21  
17  C  F  1  1497  . 67  2237  . 45  944  . 26  550  70  . 20  
17  C  F  2  1833  . 15  2744  . 09  614  . 64  550  64  . 29  
17  C F  3  1506  . 79  1877  . 52  804  . 74  525  76  . 21  
17  c  F  4  1092  . 99  1835  . 22  82S  . 39  425  64  . 80  
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TABLE 1. Continued. 
18  D N?  0  1223 .04  
18  D NF 1  3528 .00  
18  D NF 2  3439 .80  
18  D N?  3  819 .00  
18  D NF 4  0  
19  C  r  0  1219 .78  
19  C F  1  1025 .02  
19  c F 2  991 .96  
19  c  p  3  743 .97  
19  c  p  4  765 .35  
20  M F  0  2361 .04  
20  M F  1  4586 .40  
20  M F  2  3841 .11  
20  M F  3  3410 .40  
20  M F 4  3095 .82  
21  M NF 0  612 .68  
21  M NF 1  1683 .78  
21  M NF 2  1942 .82  
21  M NF 3  1986 .98  
21  M NF 4  1958 .49  
22  C  NF 0  764 .40  
22  C  NF 1  716 .62  
22  C  NF 2  899 .96  
22  C  NF 3  1255 .80  
22  C  NF 4  1605 .24  
23  C  F  0  2378 .07  
23  C  F  1  2050 .06  
23  C  F  2  2107 .92  
23  C  F  3  2487 .40  
23  C  F  4  2445 .81  
24  D  F  0  2178 .54  
24  D F  1  6568 .17  
24  D F  2  0  
24  D F  3  0  
24  D F  4  0  
25  D NF 0  462 .91  
25  D NF 1  1012 .97  
25  D NF 2  1388 .75  
25  D NF 3  1012 .63  
25  D NF 4  0  
26  C NF 0  1289 .92  
26  C NF 1  1146 .60  
26  C NF 2  1136 .80  
26  C  NF 3  891 .80  
26  C  NF 4  859 .95  
27  D NF 0  1019 .51  
27  D NF 1  1937 .30  
27  D NF 2  2224 .31  
27  D NF 3  2645 .23  
27  D NF 4  3156 .25  
. 49  604  . 13  400  59  . 96  
. 03  2139  . 58  lOOG 49  . 05  
. 03  2139  . 58  600  32  . 70  
. 98  489  . 64  125  27  .  25  
0  0  0  
. 09  775  . 73  425  65  . 33  
. 29  696  . 33  312 .5  65  . 33  
. 19  7S7  . 88  300  59  . 40  
. 73  578  . 64  225  64  . 80  
. 98  5S4  . 09  200  65  . 32  
. 11  1372  . 23  675  54  . 98  
. 17  2697  . 16  1100  38  . 16  
. 78  2067  . 25  837 .5  32  . 70  
. 23  1650  . 75  750  38  . 48  
. 90  1575  . 12  675  33  . 25  
. 87  320  . 74  225  59  . 40  
. 83  1176  . 90  550  48  . 99  
. 33  1457  . 22  550  54  . 44  
. 94  1385  . 79  562 .5  43  . 55  
. 23  1680  . 50  550  54  . 00  
. 80  720  . 73  250  43  . 60  
. 08  1201  . 94  250  43  -60  
. 54  1218  . 93  237 .5  38  . 48  
. 49  1055  . 88  287 .5  38  . 15  
. 37  1229  . 44  350  43  . 60  
. 53  1620  . 97  725  48  . 99  
. 94  1385  . 79  625  43  . 55  
. 38  1396  . 97  637 .5  59  . 40  
. 53  1667  . 06  650  54  . 44  
. 38  1352  . 29  612 .5  59  . 88  
. 85  1034  . 26  475  49  . 60  
. 00  3223  . 55  1300  21  . 99  
0  0  • 0  
0  0  0  
0  0  0  
. 01  521  . 01  200  108  . 01  
. 45  1079  . 56  375  59  . 88  
. 65  1269  . 72  300  48  .SO 
. 20  677  . 50  175  43  . 20  
0  0  0  
. 41  1350  . 61  225  38  . 16  
.  94  563  . 38  250  32  . 70  
. 76  827  . 02  200  32  . 98  
. 94  1055  . 88  175  38  . 15  
. 7  720  73  150  21 .1  30  
. 90  599  . 20  462 .5  64  . 80  
. 54  1352  . 29  675  65  . 32  
. 21  1577  . 09  775  54  .  44  
. 87  2017  . 97  800  48  . 60  
. 68  2086  . 52  750  43  . 20  
1493  
3836  
3335  
992  
0 
1577  
1352  
1432  
1065  
1230  
2674  
10939  
5031  
4629  
3425  
857  
2001 
2486  
2390  
2410  
882 
789  
1115  
1493  
2299  
2700  
2390  
2506  
2700  
2821 
2817  
25050  
0 
0 
0 
503  
1203  
1547  
1363  
0 
1713  
1618 
1698  
1201 
917  
1043  
1820 
2589  
2976  
4712  
118 
TABLE 1. Contmued. 
28  D  ? 0  2102 .10  
28  D  1  .  4267 .90  
28  D  p  2  3572 .80  
28  D  p  3  0  
28  D  F  4  0  
29  D  NF 0  1118 .71  
29  D  NF i_  1414 .46  
29  •D NF  2  0  
29  D  NF 3  0  
29  D  NF 4  0  
30  M p  0  805 .23  
30  M p  1  1089 .43  
30  M F  2  1719 .90  
30  M F  3  2078 .21  
30  M F  4  1719 .90  
31  M NF 0  696 .00  
31  M NF 1  1015 .00  
31  M NF 2  1508 .00  
31  M NF 3  1392 .00  
31  M NF 4  1682 .00  
32  M F  0  1377 .50  
32  M F  1  1841 .53  
32  M F  2  1805 .00  
32  M F  3  1658 .18  
32  M F  4  2820 .00  
33  D  F  0  3132 .00  
33  D  F  1  3269 .09  
33  D  2  2615 .29  
33  D  F  3  1160 .00  
33  D  F  4  0  
34  M F  0  1177 .08  
34  M F  1  2486 .00  
34  M p  2  2736 .00  
34  M F  3  2260 .00  
34  M F  4  2223  . 00  
35  M NF 0  882 .60  
35  M NF 1  1311 .30  
35  M NF 2  1537 .00  
35  M NF 3  2088 .00  
35  M NF 4  2871 .81  
36  C  NF 0  1533 .57  
36  C  NF 1  2516 .81  
36  C  NF 2  2938 .00  
36  C  NF 3  2511 .11  
36  C  NF 4  2203  . 50  
37  C  F  0  800 .95  
37  C  F  1  902 .22  
37  C  F  2  793 .68  
37  c F 3  928  . 00  
37  c F 4  981 .53  
. 98  1533  . 36  550  38  . 15  
. 23  1813  . 27  837 .5  38  .  15  
. 73  5407  .  95  550  38  . 48  
0  0  0  
0  0  0  
. 81  476  .  99  362 .5  48  . 60  
. 13  944  . 26  275  54  . 00  
0  0  0  
0  0  0  
0  0  0  
. 64  653  . 87  212  . 5  32  . 98  
. 23  984  . 49  287 .5  32  . 98  
. 49  866  . 16  375  21  . 80  
. 96  1149  . 86  362 .5  54  . 50  
. 37  992  . 98  300  43  . 60  
. 32  579  . 99  225  64  . 65  
. 70  560  . 10  262 .5  53  . 88  
. 52  1366  . 39  325  43  . 10  
. 04  1114  -17  300  53  . 88  
. 25  1272  . 69  362 .5  48  . 49  
. 80  861  . 17  362 .5  43  . 86  
. 83  1447  . 02  525  38  . 37  
. 28  1143  . 24  475  32  . 89  
. 14  948  . 63  400  27  . 41  
. 62  1310  . 91  587 .5  27  . 41  
. 91  2242  . 69  675  48  . 49  
. 94  2616  . 20  775  43  . 10  
. 37  2875  . 36  475  42  . 73  
. 43  1433  . 54  250  53  . 88  
0  0  0  
. 42  886  . 87  312 .5  49  . 77  
. 67  1907  . 40  550  38  . 71  
. 18  3406  . 18  600  38  . 37  
. 60  2353  . 39  550  33  . 18  
. 14  2127  . 26  487 .5  38  . 37  
. 31  522  . 23  437 .5  64  . 65  
. 05  965  . 28  650  48  . 49  
. 20  910  . 41  662 .5  37  . 71  
. 94  742  . 36  675  48  . 49  
. 69  1345  . 40  675  37  . 39  
. 09  870  . 02  475  44  . 24  
. 06  1791  . 95  612  . 5  38  . 71  
. 30  1907  . 40  650  33  . 18  
. 67  1434  . 33  500  22  .  12  
. 27  1791  . 95  487 .5  27  . 25  
. 64  621  . 97  362  . 5  64  . 65  
. 81  859  . 88  350  59  . 26  
. 17  876  . 28  325  59  . 26  
. 23  798  . 30  300  53  . 88  
. 81  1046  . 34  275  48  . 49  
2585  
4C97  
3588  
0 
0 
1589  
2844  
0 
0 
0 
1004  
1247  
1493  
2387  
2299  
828 
1302  
1839  
1958  
2512  
1807  
3598  
1924  
2286 
3232  
4126  
3465  
3156  
1733  
0 
1398  
2906  
3406  
2108 
2286 
1138  
1785  
2616 
3465  
3317  
2266 
2777  
3376  
2906  
3204  
984  
1243  
1114  
1400  
1243  
119 
TABLE 1. Continued. 
38  M NF 0  1789  . 16  2266  . 09  1211  . 64  475  33  . 18  
38  M NF 1  3295  . 83  4958  . 93  1713  . 41  875  38  .  71  
38  M NF 2  3806  . 31  4601  . 54  1713  A "  800  22  . 12  
38  M NF 3  3076  . 11  4601  . 54  1331  . 05  612  . 5  22  . 12  
38  M NF 4  3138  . 88  4958  . 93  1354  . 03  625  22  . 12  
39  C  NF 0  756  .  52  813  . 13  522  . 23  375  64  .  6  5  
39  C  NF 1  501  . 42  595  . 30  448  . 88  225  96  . 15  
39  C  NF 2  612  . 50  820  .  14  638  . 41  237 .5  69  .  44  
39  C  NF 3  658  . 12  867  . 29  805  . 18  225  69  .  44  
39  C  NF 4  1015  . 00  1366  . 39  828  . 32  262  . 5  48  . 49  
40  C  NF 0  1341  . 87  1907  . 40  723  . 16  475  49  . 77  
40  C  NF 1  2362  . 72  3048  . 46  2184  . 69  575  27  . 65  
40  C NF 2  3446  . 50  4291  . 59  2777  . 06  762 .5  27  . 65  
40  C  NF 3  4449  . 37  4958  . 93  1511  . 16  787 .5  22  . 12  
40  c  NF 4  4308  . 12  3376  . 30  1970  . 38  762 .5  22  . 12  
41  D F  0  1170  . 00  1226  . 47  425  . 02  325  53  . 41  
41  D F  1  1392  . 00  1897  . 09  984  . 64  300  48  . 49  
41  D F  2  1813  . 50  2262  . 02  1651  . 98  387 .5  48  . 07  
41  D F  3  2513  . 33  2983  . 83  2326  . 25  487 .5  43  . 10  
41  D F  4  1933  . 33  1637  . 86  1733  . 43  250  43  . 10  
42  D NF 0  1477  . 69  1907  . 40  940  . 31  425  22  . 12  
42  D NF 1  3012  . 85  3598  . 83  2932  . 39  462 .5  27  . 41  
42  D NF 2  2568  . 18  3567  . 26  2548  . 54  312 .5  22  . 12  
42  D NF 3  0  0  0  0  0  
42  D  NF 4  0  0  0  0  0  
43  C  F  0  720  . 00  776  . 32  735  . 44  300  69  .  44  
43  C  F  1  640  . 71  805  . 18  762  . 38  287 .5  64  . 10  
43  C F  2  920  . 00  1046  . 34  579  . 99  287 .5  53  . 87  
43  C  F  3  642  . 14  836  . 06  655  . 57  193  . 7  59  . 2 6  
43  C  F  4  713  . 84  1057  . 20  729  . 16  200  48  . 49  
44  M F  0  1849  . 09  2447  . 28  978  . 60  450  38  . 71  
44  M F  1  3988  . 23  4958  . 93  1970  . 38  750  27  . 65  
44  M F  2  4331  . 66  5375  . 60  1848  . 03  575  22  . 12  
44  M F  3  3992  . 6 6  5867  . 73  1471  . 87  662 .5  27  . 65  
44  M F  4  3955  . 00  4958  . 33  1791  . 95  525  22  . 12  
45  M F  0  1709  . 47  2164  . 58  1510  . 95  700  59  . 26  
45  M F  1  1755  . 00  2436  . 69  1345  . 40  712 .5  42  . 73  
45  M F  2  2010  . 66  2415  . 87  1215  . 99  650  43  . 10  
45  M F  3  2449  . 68  3009  .  56  1855  . 38  837 .5  53  .  41  
45  M F- 4  2977  . 33  4126  . 90  2022  . 69  962 .5  48  . 49  
46  M NF 0  1502  . 72  1924  . 28  877  . 72  362 .5  32  . 89  
46  M NF 1  4161  . 00  4329  . 57  2571  . 10  912 .5  21  . 93  
46  M NF 2  5660  . 00  5375  . 60  3567  . 26  1000  16  . 59  
46  M NF 3  4873  . 12  5867  . 73  2548  . 54  862 .5  16  . 59  
46  M NF 4  4590  . 62  5375  . 60  2037  . 32  812  . 5  11  . 06  
47  D NF 0  1268  . 75  1839  . 52  876  . 28  437 .5  59  . 26  
47  D NF 1  4350  .  00  5090  . 58  2728  . 68  937 .5  48  . 49  
47  D NF 2  5026  . 66  5090  . 58  3661  . 97  975  32  . 32  
47  D  NF 3  2900  . 00  9482  . 88  3661  . 97  500  32  . 32  
47  D NF 4  1667  . 50  4559  . 16  1733  . 43  287 .5  32  -32  
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TABLE 1. Continued. 
48  C  NF 0  1251 .07  
48  C  NF 1  2495 .41  
48  C  NF 2  2825 .00  
48  c NF 3  2825 .00  
48  c NF 4  1900 .00  
49  D  F  0  514 .11  
49  D  F  1  1284 .28  
49  D F  2  1408 .57  
49  D F  3  859 .26  
49  D F  4  580 .00  
50  C  F  0  2535 .56  
50  C  F  1  2155 .83  
50  C  F  2  2485 .00  
50  C  F  3  2378 .94  
50  C  F  4  2542 .50  
51  D F  0  2112 .85  
51  D  F  1  1923 .15  
51  D F  2  3351 .11  
51  D F  3  1015 .00  
51  D F  4  0  
52  D  NF 0  1265 .50  
52  D  NF 1  3333 .50  
52  D  NF 2  3712 .85  
52  D  NF 3  2280 .00  
52  D  NF 4  0  
53  D  F  0  994 .28  
53  D  F  1  1707 .77  
53  D  F  2  3712 .00  
53  D F  3  1098 .94  
53  D  F  4  0  
54  C  F  0  1355 .00  
54  C  F  1  1243 .00  
54  C  F  2  977 .14  
54  c  F  3  578 .00  
54  c F 4  0  
55  D NF 0  1450 .00  
55  D  NF 1  2289 .47  
55  D  NF 2  2706 .65  
55  D  NF 3  3305 .00  
55  D NF 4  1950 .91  
55  M NF 0  1390 .77  
55  M NF 1  3277 .00  
55  M NF 2  6215 .00  
55  M NF 3  4520 .00  
55  M NF 4 3884 .37  
57  D NF 0 1133 .63  
57  D NF 1  2204 .00  
57  D NF 2  1400 .48  
57  D NF 3  2552  . 00  
57  D NF 4 2734 .28  
. 09  886  . 87  387 .5  44  . 24  
. 26  1791  . 95  652 .5  33  . 13  
. 93  2184  . 59  750  27  .  55  
. 60  1331  . 05  525  22  . 12  
. 40  1310  . 91  500  21  . 93  
. 24  783  . 82  225  54  .  55  
. 04  1785  .  05  387 .5  48  . 49  
. 69  1243  . 81  425  48  . 49  
. 81  1138  . 31  250  59  . 25  
. 21  513  . 14  152 .5  54  . 55  
. 67  1970  . 38  700  38  . 71  
. 30  1688  . 60  575  22  . 12  
. 59  1040  . 60  550  22  . 12  
. 17  1552  . 32  500  27  . 65  
. 27  1552  . 32  450  27  . 65  
:58  1138  . 31  637 .5  48  . 49  
. 85  2164  . 58  787 .5  43  . 10  
. 53  4126  . 91  650  32  . 32  
. 59  579  . 99  175  43  . 10  
0  0  0  
. 95  616  . 59  350  27  . 65  
. 26  1158  . 42  737 .5  22  . 12  
. 54  2037  . 32  575  22  . 12  
. 62  1807  . 80  300  10  . 96  
0  0  0  
. 90  1189  . 17  450  70  . 04  
. 41  2164  . 58  662 .5  59  . 26  
. 90  3289  . 34  800  37  . 71  
. 09  965  . 28  225  43  . 10  
0  0  0  
. 95  1108  . 87  300  44  . 24  
. 33  959  . 18  275  27  . 55  
. 67  622  . 04  150  27  . 41  
. 32  627  . 49  150  27  . 65  
0  0  0  
. 44  691  . 21  625  48  . 49  
. 68  1733  . 43  937 .5  43  . 10  
. 78  1684  . 44  700  43  . 10  
. 53  2325  . 25  712 .5  32  . 32  
. 78  2512  . 25  375  32  . 32  
. 32  517  . 72  400  22  . 12  
. 17  1588  . 60  725  22  . 12  
. 46  1907  . 40  1100  15  .  59  
. 59  2558  .  11  800  16  . 59  
. 17  2265  . 09  687 .5  22  . 12  
. 28  632  . 95  537 .5  53  . 88  
. 39  1189  . 17  950  43  .  10  
. 97  1958  . 04  1237 .5  43  .  10  
. 45  1733  . 43  825  43  . 10  
. 34  2512  . 25  825  43  . 10  
2255  
3557  
4958  
5375  
1555  
715  
1958  
2242  
1243  
591  
2905  
3375  
4291  
4020  
3204  
2154  
3880  
4405  
2242  
0 
1791  
3557  
4501  
3232  
0 
1333  
2091  
4125  
1897  
0 
1791  
1434  
1158  
735  
0 
1584  
2728  
2850  
4405  
2850  
1552  
4020  
3048  
4291  
4020  
1551  
3129  
3551  
2788  
3289  
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TABLE 1. Contmued. 
58  C NF 0  1669 .28  
58  C  NF 1  1892 .75  
58  C  NF 2  2422  . 50  
58  c  NF 3  2260 .00  
58  c  NF 4 2373 .00  
59  M p  0  828 .57  
59  M p  1  1037 .89  
59  M F  2  934 .44  
59  M F  3  2242 .66  
59  M F  4  4429 .09  
60  C  F  0  • 8 87 .85  
60  C F 1  2219 .64  
60  c F 2  3154 .58  
60  c F 3  2919 .16  
60  c F 4 3107 .50  
. 82  1250  . 75  512  . 5  21  . 93  
. 09  1848  . 03  837 .5  22  . 12  
. 39  1864  . 38  850  21  . 93  
. 30  2777  . 06  650  33  . 18  
.  06  1907  . 40  525  22  . 12  
. 39  783  . 82  375  48  . 49  
. 29  667  . 21  425  48  . 49  
. 17  798  . 30  362 .5  43  . 10  
. 78  1785  . 05  725  43  . 10  
. 58  2850  . 78  1050  48  . 49  
. 35  536  . 16  275  22  . 12  
. 09  1970  . 38  687 .5  16  . 59  
. 67  1552  . 32  837 .5  33  . 18  
. 30  1511 .16  775  27  . 65  
. 27  2548  . 54  687 .5  22  . 12  
1987 
2265  
2932  
3376  
2777  
1366  
1163 
1189  
2850  
5090  
1085  
2266 
2906  
3376  
3204  
122 
TABLE 2. Experimental design for the manuscript entitled "Functional changes in isolated 
guinea-pig papillary muscle induced by monensin and digoxin". Blocks were of size two, 
each containing two muscles from the same animal. Experimental units (a single muscle) 
were randomly allocated to the treatments. Two replications of the basic incomplete block 
design were completed. M; monensin, D; digoxin, C; control, NF; non-fatigued papillary 
muscle, F; fatigued papillary-muscle, rep 1; replication 1, rep 2; replication 2. 
BLOCK C-N7 D-NT M-NF C-F D-F M-F 
R£P1 
1  X  X  
2  X  X  
J X X 
4  X  X  
5  X  X  
6  X  X  
7  X  X  
8  X  X  
9  X  X  
10  X  X  
11  X  X  
12  X  X  
13  X  X  
14  X  X  
15  X  X  
REP 2 
16  X  X  
17  X  X  
18  X  X  
19  X  X  
20  X  X  
21  X  X  
22  X  X  
23  X  X  
24  X  X  
25  X  X  
26  X  X  
27  X  X  
28  X  X  
29  X  X  
30  X  X  
123 
TABLE 3. Anova of the contraction force of guinea-pig papillary muscles for the 
manuscript entitled "Functional changes in isolated guinea-pig papillary muscle induced by 
monensin and digoxin". 
Source df Type III F Pr>F 
Method 1 0.17 0.6802 
Drug 2 5.72 0.0038 
Drug by method 2 0.85 0.4268 
Time 4 18.14 0.0001 
Method by time 4 3.36 0.0107 
Drug by time 8 11.65 0.0001 
Dn^ by method by time 8 0.78 0.6223 
TABLE 4. Anova of the initial contraction velocity of guinea-pig papillary muscles for the 
manuscript entitled "Functional changes in isolated guinea-pig p^illary muscle induced by 
monensin and digoxin". 
Source df Tj^einF Pr>F 
Method 1 0.17 0.6800 
Drug 2 5.96 0.0030 
Drug by method 2 0.03 0.9745 
Time 4 5.09 0.0006 
Method by time 4 2.87 0.0242 
Drug by time 8 3.76 0.0004 
Drug by method by time 8 0.74 0.6550 
m 
TABLE 5. Anova of the average contraction velocity of guinea-pig papillary muscles for 
the manuscript entitled "Functional changes in isolated guinea-pig papillary muscle 
induced by monensin and digoxin". 
Source df Type III F Pr > F 
Method 1 0.52 0.4701 
Drug 2 9.03 0.0002 
Drug by method 2 0.04 0.9588 
Time 4 10.92 0.0001 
Method by time 4 3.50 0.0086 
Drug by time 8 9.12 0.0001 
Drug by method by time 8 0.57 0.8002 
TABLE 6. Anova of the initial relaxation velocity of guinea-pig papillary muscles for the 
manuscript entitled "Fimctional changes in isolated guinea-pig papillary muscle induced by 
monensin and digoxin". 
Source df TypeinF Pr>F 
Method 1 0.05 0.8156 
Drug 2 3.95 0.0207 
Drug by method 2 0.25 0.7753 
Time 4 12.56 0.0001 
Method by time 4 2.65 0.0341 
Drug by time 8 5.50 0.0001 
Drug by method by time 8 1.26 0.2666 
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TABLE 7. Anova of the stimulus to response time of guinea-pig papillary muscles for the 
manuscript entitled "Functional changes in isolated guinea-pig papillary mtiscle induced by 
monensin and digoxin". 
Source df Type III F Pr>F 
Method 1 0.15 0.8285 
Drug 2 3.27 0.0401 
Drug by method 2 0.57 0.5648 
Time 4 35.44 0.0001 
Method by time 4 0.83 0.5092 
Drug by time 8 7.11 0.0001 
Drug by method by time 8 0.27 0.9740 
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TABLE 8. Contrasts that were used to test differences among the means in the manuscript 
entitled "Functional changes in isolated guinea-pig papillary muscle induced by monensin 
and digoxin". Difference between drug mean and control mean at Tl, T2, T3 and T4 was 
compared to the difference between drug mean and control mean at TO (equilibration). M; 
monensin, C; control, D; digoxin and TO, Tl, T2, T3 and T4 are time 0, 1,2, 3 and 4. 
Variable Contrast Pr > T 
Contraction force M-TO / C-TO ~M-T4/C-T4 0.0005 
M-TO / C-TO ~M-T3/C-T3 0.0062 
M-TO/C-TO ~M-T2/C-T2 0.0199 
M-TO / C-TO — M-Tl/C-Tl 0.0093 
D-TO / C-TO -~D-T4/C-T4 0.0004 
D-TO/C-TO-  D-T3 / C-T3 0.0115 
D-TO / C-TO • -D-T2/C-T2 0.9929 
D-TO/C-TO-  D-Tl / C-Tl 0.0153 
Initial contraction M-TO / C-TO ~M-T4/C-T4 0.0314 
velocity M-TO/C-TO ~M-T3/C-T3 0.0774 
M-TO / C-TO ~ M-T2 / C-T2 0.3533 
M-TO/C-TO -M-Tl/C-Tl 0.0937 
D-TO / C-TO • ~D-T4/C-T4 0.1346 
D-TO/C-TO-~D-T3/C-T3 0.5622 
D-TO/C-TO-~D-T27C-T2 0.9025 
D-TO/C-TO-~D-T1/C-T1 0.0268 
Average M-TO / C-TO ~ M-T4 / C-T4 0.0003 
contraction M-TO/C-TO — M-T3/C-T3 0.0056 
velocity M-TO / C-TO ~M-T2/C-T2 0.0044 
M-TO/C-TO ~ M-Tl / C-Tl 0.0142 
D-TO/C-TO-~D-T4/C-T4 0.0034 
D-TO/C-TO-~D-T3/C-T3 0.1171 
D-TO / C-TO • -D-T2/C-T2 0.5088 
D-TO/C-TO--- D-Tl / C-Tl 0.0356 
Table?. Continued. 
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Initial relaxation M-TO / C-TO — M-T4 / C-T4 0.0160 
velocity M-TO / C-TO ~ M-T3 / C-T3 0.0110 
M-TO / C-TO ~ M-T2 / C-T2 0.0248 
M-TO / C-TO — M-Tl / C-Tl 0.1405 
D-TO / C-TO ~ D-T4 / C-T4 0.1875 
D-TO / C-TO — D-T3 / C-T3 0.8631 
D-TO / C-TO — D-T2 / C-T2 0.0015 
D-TO / C-TO — D-Tl / C-Tl 0.0732 
Stimulus to M-TO / C-TO —M-T4/C-T4 0.8279 
response time M-TO / C-TO — M-T3 / C-T3 0.3437 
M-TO / C-TO — M-T2 / C-T2 0.1591 
M-TO / C-TO — M-Tl / C-Tl 0.3510 
D-TO/C-TO ~D-T4/C-T4 0.0001 
D-TO / C-TO ~ D-T3 / C-T3 0.0001 
D-TO/C-TO ~D-T2/C-T2 0.0008 
D-TO / C-TO ~ D-Tl / C-Tl 0.2561 
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TABLE 9. Anova of dose response experiment for monensin and digoxin in the 
manuscript entitled "Digoxin and monensin induced changes of intracelltilar Ca""^ 
concentration in isolated guinea-pig ventricular myocyte". 
Source df SS 
TRT 6 11.51 
Error 14 2.47 
Corrected 
Total 20 13.98 
M S  F  P r > F  
1.92 10.87 0.0001 
0.17 
TABLE 10. Anova of "weakened" cell experiment in the manuscript entitled "Digoxin and 
monensin induced changes of intracellular Ca^"^ concentration in isolated guinea-pig 
ventricular myocyte". 
Source df SS MS F P r > F  
TRT 2 9.29 4.64 17.63 0.0031 
Error 6 1.58 0.26 
Corrected 
Total 8 10.87 
TABLE 11. Anova of Na"^-free experiment in the manuscript entitled "Digoxin and 
monensin induced changes of intracellular Ca^"^ concentration in isolated guinea-pig 
ventricular myocyte". 
Source df SS MS F P r > F  
TRT 2 5.19 2.59 8.92 0.0160 
Error 6 1.74 2.90 
Corrected 
Total 8 6.93 
